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'Usefulness of home spirometry in childhood asthma' 
1 The unreliability of written PEF diaries can be overcome by using home spirometry. 
(this thesis) 
2 The variable concordance of PEF variation to other parameters of asthma severity 
limits the usefulness of home spirometry for monitoring disease severity in 
childhood asthma. (this thesis) 
3 The variable concordance of changes in PEF variation to changes in symptom scores 
in children with asthma makes it unclear to patients in asthma self-management, 
how they should respond to what change in which parameter. (this thesis) 
4 The reliable single reference value of lung function variation for schoolchildren, 
obtained by home spirometry, is substantially lower than the one previously 
described using a traditional peak flow meter and a written diary. (this thesis) 
5 The marginal contribution of lung function variation to make the diagnosis of 
asthma limits the usefulness of home spirometry as a diagnostic tool for childhood 
asthma in children with nonspecific cough or breathlessness. (this thesis) 
6 The theoretical benefit of the ability of home spirometry to measure FEV1 in 
addition to PEF did not bear out in practice. (this thesis) 
7 Based on the limited usefulness of home spirometry, and the proven superiority of 
monitoring symptoms over lung function variation, international guidelines should 
discourage the use of lung function monitoring both for diagnosing and following 
up asthma in children. (this thesis) 
8 The way we communicate with others and with ourselves ultimately determines 
the quality of our lives. {Anthony Robbins) 
9 Any fool can make things bigger, more complex, and more violent. It takes a touch 
of genius - and a lot of courage - to move in the opposite direction. (Albert 
Einstein) 
10 Het zorgen voor (eigen} kinderen in de privesfeer blijkt een van de meest leerzame 
stages in de opleiding tot kinderarts. 
11 Happiness is not something ready made. It comes from your own actions. (Dalai 
Lama) 
Alwin Foppe Jan Brouwer, Groningen, 20 januari 2010 
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Chapter 1 
Introduction 
Parts of this introduction were previously published as: 
Brouwer AFJ, Brand PLP 
Asthma education and monitoring: what has been shown to work. 
Paediatric Respiratory Reviews 2008;9:193-200. 




Asthma is the most common chronic disease of childhood, with millions of children 
affected worldwide.1 Over the past decade, guidelines for the diagnosis and 
treatment of asthma, such as the Global Initiative on Asthma (GINA) guidelines, have 
increasingly adopted an evidence-based approach for retrieving and analysing 
published studies.2 
These evidence-based asthma guidelines divide the principles of care in childhood 
asthma into a number of key steps. 
Diagnosis. The first step, obviously, is to make the diagnosis of asthma. Asthma in 
children, and adults, is a clinical diagnosis.2 There is no gold standard test for 
asthma. The main diagnostic tool for asthma is the history, with symptoms such as 
episodic breathlessness, wheezing, cough, and chest tightness. Because patients and 
parents vary considerably in their interpretation of "wheeze" (which may include 
any kind of noisy or difficult breathing), 3A the presence of expiratory wheeze, as a 
sign for the presence of airflow obstruction, should be confirmed by a health care 
professional, either by physical examination or by lung function testing.2'4'5 Hospital 
based spirometry can be used to confirm the diagnosis. However, due to the 
variation of airway obstruction, a key feature of asthma, these snap-shot lung 
function tests lack sensitivity.2 Repeated daily home measurements of peak 
expiratory flow (PEF) have therefore been advocated to document the variation of 
lung function, both for making the diagnosis,6 and for monitoring the response to 
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Figure 1. Mechanical peak 
flow meters. Peak flow 
meters use a sliding 
marker which moves 
during forced expiration 
along a numbered scale. 
The results are recorded 
by patients in an 
accompanied written peak 
flow diary. 
asthma treatment.2'7 Originally, such home monitoring of PEF was performed on 
simple, cheap, mechanical PEF meters (figure 1), and measurements were recorded 
in a written diary. 
These written PEF diaries, however, proved to be very unreliable, with as much as 
50% of values in the diary either being invented or recorded incorrectly.8 As a 
consequence, results from earlier studies using written PEF diaries to measure 
variation of lung function should be questioned and reassessed.9 The use of 
electronic home spirometers (figure 2) has been advocated as a suitable alternative 
to mechanical PEF meters to establish the variation of lung function. These devices 
store the recorded lung function values electronically on a microchip, and are 
10 
Figure 2. Koko Peak Pro. 
Electronic hand held home 
spirometer, measuring 
peak flow, FEV1 and FVC. 
The results are saved in an 
incorporated microchip 
and can be downloaded 
on a computer. 
Chapter 1 
supposed to be much more reliable than written PEF diaries.2'7'8 The value of home 
spirometry in the diagnosis of asthma has never been formally studied, however. 
Identification of triggers, and reduction of exposure to relevant triggers. A second 
important element of childhood asthma care is the identification of stimuli that 
induce symptoms {"triggers") and reduction of exposure to these triggers. 
Exacerbations of asthma can be triggered by a number of stimuli, including viral 
respiratory tract infections, exercise, exposure to allergens, or exposure to 
pollutants such as cigarette smoke and traffic exhaust particles.10-12 When possible, 
11 
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reducing exposure to these triggers may improve asthma control and reduce 
medication needs.2'7 '12 
Pharmacotherapy. Although asthma is not curable, pharmacologic interventions to 
treat established asthma are highly effective in controlling symptoms, reducing or 
preventing exacerbations, and improving quality of life, lung function, and airway 
hyperresponsiveness.13'14 Inhaled corticosteroids {ICS) are the cornerstone of asthma 
treatment, and these drugs should be prescribed on a daily basis to all children with 
persistent symptoms (complaints on more than two days per week).2'7'13' 14 In 
addition to these daily preventive drugs, each patient should be provided with short­
acting bronchodilators for quick relief of symptoms on an as needed basis.2'7 If this 
approach to treatment fails to control the disease satisfactorily, drug treatment is 
increased in a stepwise fashion.2'7 Conversely, when asthma control is maintained 
for at least three months, treatment can be stepped down in reverse order. 2'7 The 
outcome of pharmacologic intervention studies almost invariably includes the 
number of exacerbations and the degree of lung function variation over time. This is 
usually assessed by mechanical PEF meters and written PEF diaries.15 Because of the 
unreliability of these written PEF diaries, studies using home spirometry to assess 
and monitor treatment response are preferable. Very few such studies are available, 
however. 
Education. A key element in childhood asthma care is education of patients and 
parents. This includes an explanation of the different aspects of the disease and its 
treatment, and teaching the management skills needed to achieve optimal asthma 
control. Educating asthmatic children and their parents is a complex intervention, 
and it is difficult to assess which components of education are particularly useful. A 
prerequisite for education and self-management of paediatric asthma is the 
development of a partnership between the asthma patient, his or her parents, and 
the health care professionals.2 Building such a partnership requires good 
communication skills by the health care providers.16 The main aim of the partnership 
is to provide patients with asthma the knowledge, confidence and skills to control 
their own condition, with guidance from health care professionals, and ultimately to 
establish a degree of independence. 17 This requires a comprehensive education 
package, delivered in repeated sessions over prolonged periods of time. 
12 
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One of the key elements in asthma education is teaching the patient how to respond 
to deterioration of the disease. This requires a certain degree of monitoring of 
disease activity, and this is the final main element of childhood asthma care. 
Monitoring of disease activity. Asthma guidelines recommend two approaches to 
objective monitoring of disease activity. Office-based assessment of lung function is 
usually performed by obtaining full expiratory flow-volume curves to assess airway 
obstruction. If obstruction is present, its reversibility can be tested by repeating 
flow-volume curves after inhaling a bronchodilator. The degree of airway 
hyperresponsiveness assessed by bronchial challenge tests is not routinely 
recommended.2 Although there are no RCTs demonstrating the usefulness of annual 
office spirometry in the follow-up of childhood asthma, 18 ample observational 
evidence supports its use.19'20 Inflammatory markers such as fractional exhaled nitric 
oxide (FeNO) are still being evaluated for potential use in monitoring disease activity, 
but are increasingly used in clinical practice.2 Although evidence to support the use 
of home monitoring of PEF is lacking,9' 18'2 1'22 and accumulating evidence suggests 
that it does not contribute to optimizing asthma control, 21-23 asthma guidelines still 
advocate the use of home PEF monitoring.2'7 Most studies on home PEF monitoring 
used written PEF diaries. There is a need, therefore, for additional studies on 
electronic home spirometry as a monitoring tool in childhood asthma. 
Because education is a key issue in successful asthma management, the following 
section of this introduction will summarize and discuss the results of systematic 
reviews on education in childhood asthma. As the majority of educational 
interventions in asthma also include monitoring of disease activity, the different 
approaches to asthma monitoring in children will be discussed. This leads to the 
presentation of the individual studies on home spirometry in this thesis. 
13 
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Systematic reviews of education in asthma 
It is not clear whether randomized controlled trials and meta-analyses of results of 
such studies in systematic reviews are valid and useful to study complex 
interventions where a comprehensive set of medical deliberations, technical skills 
and local circumstances, which are all difficult to standardize, may influence the 
outcomes studied.24 Because the education of asthmatic children and their parents 
is such a complex intervention, evaluating the effects of this intervention with 
evidence-based medicine techniques is fraught with difficulties. It should come as no 
surprise, therefore, that systematic reviews of education in childhood asthma have 
come to divergent conclusions, 25'26 and that many studies have been eliminated 
from systematic reviews because of insufficient methodological quality or clinical 
heterogeneity. 23'25'27'28 
The Cochrane Library contains four systematic reviews on educational strategies in 
childhood asthma. 
Educating children who have attended the emergency room for asthma.27 
This review included eight studies involving 1407 subjects. Compared to controls, 
education did not reduce subsequent emergency department visits (relative risk 
0.87, 95% confidence interval 0.37-2.08) or other healthcare use variables. Clinical 
heterogeneity was a major problem, both within and between studies. Perhaps the 
most striking finding of this review was that most studies showed modest beneficial 
effects (figure 3), 29'30 but this was offset by a single large trial showing the opposite 
effects.31 
This latter study was conducted in New Zealand in the early 1980s. Usual care was 
compared to education which consisted of monthly home visits by asthma nurses. 
The subjects were assessed 6 months later by a postal, self administered 
questionnaire. European children in the education group were more likely to return 
to hospital for severe attacks than those in the control group, but such differences 
were not seen in Polynesian children. The main limitation of this study is that fewer 
than one-third of children used inhaled corticosteroids.31 Although this study had a 
major impact on the results of the systematic review, 
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Figure 3. Effect of education on short-term and long-term asthma relapse rates in 
children admitted to hospital for acute severe asthma.29'30 Black bars represent A) 
relapse or B) re-admissions; gray bars represent A) no relapse or B) no re­
admissions. 
the treatment of the children involved is no longer representative of current 
practice, and the results can, therefore, not be extrapolated to today1s children with 
asthma. 
Educational interventions for asthma in children32 
This review evaluated the effects of education in children with chronic persistent 
asthma. This review, which was also published as a journal article,28 included 32 
studies involving 3706 patients. Asthma education programmes were associated 
with moderate improvements in a number of clinically relevant asthma outcome 
measures (table 1).32 
Although this meta-analysis provided strong support for the usefulness of education 
as a general approach, it also suffered from clinical heterogeneity. In particular, it 
was noted that there were many different educational approaches and that direct 
comparisons between these different educational programmes were lacking. Thus, it 
was impossible for the reviewers to judge which educational approach was most 
effective. The only comment made was that the effects of peak flow-based 
education and monitoring programmes seemed to be larger than those based on 
education alone.28 
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Table 1. Beneficial effects of educational interventions in children with chronic persistent 
asthma (systematic review of randomized trials comparing education to regular care without 
education).28'32 
Improvement in SMD 95%CI 
Lung function (PEF or FEV1) 0.50 0.25 to 0.75 
Absence from school 0.14 0.04 to 0.23 
Number of days with restricted activity 0.29 0.09 to 0.33 
Visits to emergency department 0.21 0.09 to 0.33 
PEF: peak expiratory flow; FEV1: forced expiratory volume in one second; SMD: standardized mean 
difference; 95% Cl: 95% confidence interval. 
Written action plans for asthma in children and adults25 
This systematic review examined whether a written asthma self-management plan 
improved outcome (as compared to no written action plan). This review, published 
in 2004, comprised seven studies and 967 patients (primarily adults; one study 
involved 46 children), and showed no consistent effect of a written action plan on 
any asthma outcome.25 The main drawback of this analysis from a paediatric point of 
view was that only one study included children and that these children were not 
analysed separately from the adults. In addition, large differences between the 
different educational programmes were again noted. 
Another systematic review, published as a journal article in the same year but not 
included in the Cochrane database, also explored the usefulness of written action 
plans in asthma management. This review included 26 trials, and found that 
individualized written action plans based on personal best peak flow, using two to 
four action points and recommending both inhaled and oral corticosteroids for 
treatment of exacerbations, consistently improved asthma health outcomes.26 In this 
meta-analysis, no differences were found between peak flow and symptom-based 
plans. 
At face value, it is quite striking that two systematic reviews with the same aim and 
similar methodology include a highly different number of studies, and come to 
completely opposite conclusions. As discussed above, however, this is an illustration 
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of the problems involved in analysing results of complex interventions with methods 
developed for another purpose (namely, to evaluate drug therapy). 
Written action plans for asthma in children23 
The most recent Cochrane review analysed the results of studies on the effects of 
written asthma plans in children. This analysis comprised four trials involving 355 
children. Children following a symptom-based written action plan had a 27% lower 
risk of exacerbation requiring acute medical care than children on a peak flow-based 
action plan (relative risk 0.73, 95% Cl 0.55-0.99); the number needed to treat was 9 
(95% Cl 5-138). Conversely, children assigned to a peak flow-based education plan 
had slightly fewer symptomatic days per week than children assigned to a symptom­
based action plan (mean difference 0.45 days; 95% Cl 0.04-0.86 days).23 The review 
was unable to answer the question whether written action plans per se improved 
asthma outcomes because no studies compared a written action plan versus regular 
care. Other weak points in this review were the small number of studies involved, 
and, again, clinical heterogeneity.33 
What can be learned from systematic reviews on 
education in childhood asthma? 
It is clear from the discussion above that very few firm conclusions can be drawn on 
the effects of education in children with asthma. There is little doubt that education 
in itself is useful (table 1).28'32 This is, of course, both not very surprising and not very 
helpful to practice - no paediatrician in his or her right mind would try to treat a 
chronic condition in a child without at least some basic explanation to the child and 
parents on the nature of the disorder and the logic of its treatment. The challenge, 
therefore, is not to justify education per se, but to try and tease out which 
components of education are useful and which are well-intended but superfluous. 
Unfortunately, the systematic reviews performed to date do very little to address 
this challenge. For example, even though written action plans have been 
promulgated as the standard of care over the last 20 years in children with asthma, 
no study has evaluated its efficacy in children.34 This absence of good quality 
evidence may help to explain why so few patients actually receive a written action 
plan in practice,34'35 despite the guidelines' insistence on its importance.2 This also 
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illustrates that the evidence base for such recommendations on asthma education in 
'evidence-based' guidelines is, at best, shaky. Because it is difficult to study asthma 
education in randomized controlled trials, additional support for recommendations 
in guidelines should come from observational studies. 
The problem of clinical heterogeneity 
So far, all studies on asthma education have lumped together all patients with 
asthma. All systematic reviews have noted that clinical heterogeneity is a major 
problem, not only because of the differences between educational programmes, but 
also because of differences between asthma patients. Any given educational 
approach may be useful in some children with asthma but not in others. What is 
useful for school-aged children may not work in toddlers.36 What is valid for chronic 
persistent asthma may not be valid for children hospitalized for asthma. Even within 
studies on acute severe asthma in children, clinical heterogeneity appears to be a 
major problem:37 not every asthma exacerbation appears to be the same. Although 
an exacerbation of asthma can occur against the background of poor asthma 
control,33 it has also been shown that children with well controlled asthma may 
show isolated, sometimes quite severe, exacerbations associated with viral 
infections, and this may be viewed as a distinct asthma phenotype in childhood.38 
The importance of different asthma phenotypes is being increasingly recognized 
across all ages.39 Clearly, in future studies on any therapeutic intervention in 
childhood asthma, a clear and detailed description of the patient population studied 
is needed. Only then can we begin to understand in what way and to what extent 
different asthma phenotypes in childhood respond differently to educational 
interventions. 
Education : what should be explained to parents and children? 
No studies have evaluated which components of asthma education determine its 
success. Virtually all studies have examined a comprehensive package of educational 
and monitoring strategies {table 2) and, because this is the only approach that has 
been extensively studied, guidelines tend to recommend application of the entire 
programme.2 Although this may be regarded as the safest approach {the effects of 
this package have been demonstrated), it is not necessarily the most effective one. 
18 
Chapter 1 
In particular, there is good evidence against home monitoring of lung function, as 
will be discussed below. 
As outlined above, it is only logical that children with a chronic condition such as 
asthma and their parents should receive information on the causal mechanisms of 
the disorder. Remarkably little is known, however, on the content of this information 
or how it should be presented to patients and their parents. A recent study showed 
that most adult patients with asthma preferred an active or at least collaborative 
role in the management of their disorder, but that most perceived their role as 
passive.40 Similar results have been found in parents of children with eczema,41 but 
to our knowledge this has never been studied in children with asthma. There is some 
evidence that family interaction and dynamics may play a role in how parents view 
their child's disease and how likely they are to follow educational advice.42,43 A 
questionnaire has been developed to assess these 'family asthma management 
routines',44 but the usefulness of this questionnaire has not been fully elucidated. 
Numerous asthma education packs are available online (e.g. at www.ginasthma.org). 
Most centres will adapt these to their own needs and circumstances. For example, 
based on the evidence available to date and our own experience in providing asthma 
education to hundreds of patients, we have put together an extensive information 
package for children with asthma and their parents. After the diagnosis has been 
Table 2. Components of a typical asthma education package 
Education and training 
Supportive treatment 
Monitoring 
1 Explanation of the causal mechanisms of the disorder, trigger 
factors and pattern of symptoms 
2 Explanation of difference between maintenance treatment 
and symptomatic treatment 
3 Instruction and practice of correct inhalation technique 
4 Explanation of deleterious effects of tobacco smoke exposure, 
and support to prevent exposure of child to tobacco smoke 
5 Discussion of role of allergen exposure, and support to avoid it 
6 Home monitoring of symptoms or peak flow 
7 Instruction on self-management: what to do when asthma 
deteriorates (for example, written action plan) 
19 
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made and a treatment plan has been outlined, the attending paediatrician discusses 
the salient information items with the patient and parents. This is then reinforced by 
repeated education sessions with one of our asthma nurses,45 by the written 
information package and by a list of reliable online information sources (including 
our national Asthma Foundation). We aim for regular and long-lasting follow-up 
visits if necessary, and at every follow-up visit, the importance of maintenance 
treatment is stressed, and questions and concerns are addressed. 
Instruction on correct inhalation technique 
Inhaled asthma treatment can only be expected to be effective if the inhaler is used 
properly. In accordance with others,46,47 we found that many children with asthma 
use thei r inhaler incorrectly.48 To our surprise, however, this was not only due to lack 
of proper instruction; poor inhalation technique was also common in children who 
had received inhalation instruction in primary care.48 This prompted us to study the 
determinants of correct inhalation technique in children in more detail.49 Two 
hundred children attending our asthma clinic for a scheduled follow-up visit were 
interviewed about the inhalation instruction they had received in the past, and 
subsequently demonstrated the use of their own inhaler. Inhalation technique was 
scored using a validated scoring system identifying steps considered to be essential 
for reliable drug delivery.48'49 Even though 99% of patients had received inhalation 
instruction and 96% of patients were confident that they could use their inhaler 
correctly, 92/200 children tested (46%) used their inhaler incorrectly. Correct inhaler 
use was not dependent on age, sex, type of inhaler, or duration or severity of 
asthma. Two features of inhalation instruction, however, were significantly 
associated with correct inhaler technique (table 3). 
Table 3. Determinants of correct inhalation technique in 200 children with asthma, attending a 
secondary care asthma clinic {adapted from49) .  
Characteristic 
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Patients (or parents, depending on the age of the child) who had to demonstrate the 
use of their inhaler to the asthma nurse during instruction sessions were more likely 
to maintain a correct technique than patients who were only passively instructed. By 
far the most important factor, however, was repetition of inhalation instruction 
(table 3). The odds of a correct inhalation technique increased eightfold when 
inhalation instruction sessions were repeated (95% Cl 3.2-21.5). The usefulness of 
repeated active demonstration of correct inhalation was then tested prospectively in 
47 newly referred patients. Only after three repeated instruction sessions over a 6-
month period did >95% of patients use their inhaler correctly.49 This illustrates that 
achieving and maintaining a correct inhalation technique is difficult, and requires 
time and repeated effort. 
Two observations from our own clinic support the usefulness of this approach. First, 
in a randomized trial comparing follow-up by asthma nurse or paediatrician in 
children with asthma, 74 newly referred patients were enrolled in our asthma 
management programme, comprising extensive repeated education and repeated 
inhalation instruction sessions.45 There were no differences between the two study 
groups in any of the asthma outcome parameters studied, showing that childhood 
asthma can be effectively and cost-effectively followed up by asthma nurses.45 '50 All 
74 patients referred because of troublesome asthma showed significant and 
clinically relevant improvements in airway hyperresponsiveness and quality of life 
after 1-year follow-up at our clinic.45 This was not due to more intensive medication 
use. In fact, the mean inhaled steroid dose could be reduced by, on average, 26% 
(figure 4). The proportion of patients with a correct inhalation technique increased 
from 65% at baseline to 95% after 1-year follow-up. This clearly illustrates that with 
extensive education, training in the correct use of the inhaler device and close 
follow-up, childhood asthma can be well controlled. Second, a cross-sectional 
analysis of lung function values in 301 children with asthma attending our clinic 
showed, on average, normal FEV1 values in these patients. In fact, reduced lung 
function levels were only observed in patients experiencing an acute episode of 
asthma, or in those with poor adherence to maintenance medication.51 
These observations clearly illustrate that with extensive education, training in the 
correct use of the inhaler device, and close follow-up, childhood asthma can be well 
controlled and normal lung function maintained. 
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Baseline 3 6 1 2  
Figure 4 .  Mean (SE) dose of inhaled corticosteroids ( ICS) during the study for 
patients followed by a paediatrician (o, n=28) or asthma nurse (•, n=30) and 
who had already been prescribed an ICS by their general practitioner. 
Reproduced with permission from Kamps et al.45 
Monitoring: symptoms or peak flow? 
An integral component of asthma education and follow-up is monitoring of disease 
activity. Self-management of asthma in children relies heavily on the ability of 
patients and parents to gauge the severity of the disorder on a day-to-day basis, and 
to respond appropriately to imminent deterioration. Home monitoring can be either 
symptom-based or peak flow-based. Guidelines prefer home monitoring of peak 
flow, primarily because it is assumed that many children with asthma are 'poor 
perceivers' of airway obstruction, and because it is assumed that peak flow-based 
self-management improves asthma outcomes.2 There is no good evidence to support 
either assumption, however. 
First, poor perception of airway obstruction is more common in children with 
undiagnosed asthma than in children with diagnosed asthma.52 In addition, little is 
known about the variation of accuracy of symptom perception between children 
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with asthma. Finally, the clinical significance of differences in symptom perception 
between children in determining and maintaining asthma control is unclear. In a 
large group of asthmatic ch ildren followed up for 1 year, for example, poor 
perception of dyspnoea was not associated with emergency visits for asthma or poor 
lung function.53 
Second, systematic reviews on the relative merits of symptom-based and peak flow­
based self-management plans have yielded conflicting results.23'26'28 As mentioned 
earlier, the main disadvantage of home peak flow monitoring is that paper diaries 
are hopelessly unreliable, with as much as half of the data either invented or 
incorrectly recorded.8 It is assumed that th is can be overcome by the use of 
electronic home spirometers. Ch ildren show h igh adherence to home spirometry 
and perform these measurements in a technically correct manner.54 So far, one 
randomized trial compared symptom-based self-management to home spirometer­
based self-management in 90 children with asthma, and found no differences in 
asthma outcomes over a 3-month period.22 
Previous studies using paper PEF diaries have examined the relationship between 
peak flow or peak flow variation and other indices of asthma severity, and found 
that monitoring PEF alone is insufficient to assess asthma severity adequately.55-57 A 
20 month longitudinal study in 104 ch ildren found poor concordance of changes in 
PEF variation with changes in other parameters of asthma severity.56 Another 12 
month longitudinal study in 192 children did find an association between lower 
respiratory tract symptoms and falls in PEF in children.55 However, in that particular 
study, half of the exacerbations were preceded by respiratory symptoms 2 days prior 
to a fall in PEF. Even more surprising, about 40% of the registered PEF episodes were 
not accompanied by symptomatic events.55 A diagnostic study in 120 ch ildren found 
a low sensitivity and a high false negative ratio using PEF variation to make the 
diagnosis of asthma.57 All these studies recommend PEF monitoring, but only as an 
additional measurement, and not as an isolated monitoring or diagnostic tool. Due 
to the unreliability of written PEF diaries,8 however, it is uncertain whether these 
earlier results are valid. Therefore, the relationship between asthma severity and 
peak flow variation should be studied by electronic home spirometry. Despite its 
proposed usefulness,2'58 studies on the reliability and clinical application of home 
spirometry in ch ildren are lacking. Only one study examined the validity of electronic 
home spirometry.59 It compared its values to those obtained by hospital spirometry, 
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showing reasonably accurate and reproducible measurements of PEF and FEV1 .
59 The 
potential benefits of the ability of home spirometry to measure FEV1 in addition to 
PEF has yet to be assessed.53 
Conclusions 
Education of ch ildren with asthma and their parents is effective in improving 
clinically relevant outcomes. Common sense dictates that these improvements are 
most likely to be achieved if the health care team, the ch ild with asthma and his or 
her parents work together in a partnership.2 Th is should include extensive education 
of the patient and parents on causal mechanisms of asthma, identification of trigger 
factors and treatment. Adherence to maintenance medication and correct use of the 
inhaler device are key factors in obtaining asthma control. Ach ieving and maintaining 
proper inhalation technique requires time and repeated effort. However, a crucial 
part of these programmes is probably the level of agreement between the doctor 
and the patient. Once th is has been ach ieved and a partnership has been 
established, follow-up can be performed by an asthma nurse. Although home 
monitoring of lung function is intuitively appealing because it aims at assessing one 
of the key characteristics of asthma, variation of airway obstruction, its usefulness in 
the long-term management of asthma is not supported by evidence. Most studies on 
home monitoring of lung function used mechanical PEF meters and written PEF 
diaries which are unreliable. Because electronic home spirometers have the 
advantage of accurately reflecting diurnal and day-to-day changes in lung function, 
home spirometry may be a useful tool in making the diagnosis of asthma and 
monitoring the disease. 
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Chapter 1 
The main aim of this thesis is to explore the usefulness of measuring lung function 
variation by electronic home spirometry in the diagnosis and monitoring of 
childhood asthma. For th is purpose, we designed a number of specific studies 
examining the validity of home spirometry, its usefulness as a monitoring tool, and 
its diagnostic value. 
Validity: In all studies, we used the same electronic portable spirometer (Koko Peak 
Pro, Ferraris, Louisvi lle, Colorado, USA: figure 2) Th is home spirometer has been 
validated in vitro using a precision waveform generator (Pulmonary Waveform 
System; MH Custom Design and Mfg, Midval, UT, USA) demonstrating its agreement 
with performance standards as recommended by international guidelines.60 It is 
fairly cheap, approximately € 40 a piece, easy to use and only needs calibration once 
during manufacturing. In chapter 2, we examined the validity of th is home 
spirometer in vivo by studying the agreement between lung function variables 
measured by home spirometry and those obtained by hospital lung function 
measurement on a pneumotachograph. 
Monitoring: The usefulness of electronic home spirometry to monitor the severity 
and variation of airway obstruction in asthma after maintenance treatment with ICS 
has been instituted is described in chapter 3. In th is study, we assessed the 
relationsh ips between lung function variation, asthma symptom scores and other 
indices of asthma severity. 
In clinical practice, the dose of ICS is commonly adapted in response to changes in 
symptoms and need for bronchodilators. 2 Some clinicians even support daily 
titration of ICS dose in response to daily variation of symptoms and need of rescue 
therapy.61 These approaches of variable ICS dosing are based on the assumption that 
patients are able to recognize airway obstruction reliably. The agreement between 
symptoms and lung function has been studied in a hospital setting in patients with 
acute severe asthma.53'62'63 Both cross-sectional and longitudinal studies have shown 
poor concordance between lung function and respiratory symptoms, 64-66 but these 
studies are hampered by the use of unreliable written PEF diaries. In chapter 4, we 
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used home spirometry to study prospectively whether symptoms prompting the use 
of reliever therapy are accompanied by changes in lung function. 
Diagnosis : A population based study using written PEF diaries showed considerable 
overlap in PEF variation between healthy and asthmatic children,67 suggesting that 
measuring diurnal PEF variation was not a useful diagnostic tool for asthma in 
children.57 Given the unreliability of written PEF diaries, however, we questioned the 
validity of this assumption. In chapter 5, we describe a study aimed at establishing 
reliable reference values of lung function variation using electronic home 
spirometry. Chapter 6 describes a prospective study to explore the usefulness of 
lung function variation in diagnosing asthma in children with nonspecific respiratory 
symptoms. 
Chapter 7 provides a summary of the results of the studies in this thesis, and the 
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Abstract 
Background 
The accuracy of electronic portable home spirometers has been demonstrated in 
vitro using computer-based waveforms. We assessed the agreement in vivo between 
measurements of lung function on an electronic spirometer {Koko Peak Pro) and 
those obtained by the gold standard, a hospital lung function laboratory 
pneumotachograph. 
Methods 
Fifty stable asthmatic children {33 boys), aged 6-17 years, performed peak 
expiratory flow {PEF) and forced expiratory volume in 1 sec {FEV1) measurements 
according to international guidelines on a portable home spirometer and on the 
hospital pneumotachograph in random order. All measurements complied to 
standard quality criteria. The PEF and FEV1 values recorded with the home 
spirometer and on the hospital pneumotachograph were compared. 
Resu lts 
All children performed reproducible high-quality measurements on both 
spirometers. PEF values on the home spirometer were considerably lower than on 
the laboratory pneumotachograph {95% Cl for difference in PEF 14-30 L/min; 
p<0.0001). Individual differences in PEF between the two devices could be >100 
L/min. The FEV1 values were slightly, but significantly, lower on the home spirometer 
{95% Cl for difference in FEV1 0.02-0.1 L; p=0.0018). 
Conclusions 
A home spirometer provides reproducible and quality acceptable measures in 
children with asthma when performed under professional supervision and 
encouragement. Mean PEF and FEV1 values recorded on this home spirometer are 
significantly lower than those on a hospital pneumotachograph, and individual 
differences may be large. Therefore, home spirometry may not be interchanged with 




Lung function measurements, for example peak expiratory flow (PEF) and forced 
expiratory volume in the first second (FEV1), are used world-wide in the treatment 
and follow-up of asthma in children and adults. 1-3 PEF is primarily a measure of the 
patency of large intrathoracic airways and is very dependent of the effort made by 
the patient, whilst FEV1 is thought to reflect the calibre of medium-sized airways and 
is less effort dependent.4'5 Spirometers have to meet quality criteria formulated by 
international boards, such as the American Thoracic Society (ATS), and have to be 
calibrated regularly.5 Such lung function measurements mostly take place in 
hospitals and only provide a 'snapshot' impression of lung function in asthma. The 
characteristic variability in lung function can better be assessed by repeated home 
measurements of lung function.1'2 In the past, th is was done by using mechanical PEF 
meters and hand-written PEF-diaries.6-8 Research has shown, however, that these 
are highly unreliable, and the use of home spirometers with electronic data logging 
has been advocated since.9-11 In addition to their reliability, these electronic home 
spirometers have the advantage of measuring both PEF and FEV1, which improves 
their profile as devices for monitoring asthma and are promising devices for lung 
function measurements at home. These portable electronic home spirometers meet 
the quality criteria based on computer-generated wave-forms.3'5 However, studies 
have shown differences in quality of these devices and in quality of measurements 
when used in different target disease populations.12-15 It is unclear whether lung 
function values derived from a validated portable home spirometer can be 
interchanged with lung function values derived from a hospital-based 
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pneumotachograph. Therefore, in addition to the physical validation, home 
spirometers need also be validated in vivo in the target disease population.15 
This study was designed to assess the accuracy of an electronic home spirometer 
(Koko Peak Pro, Ferraris, Louisville, CO), in measuring PEF and FEV1 in a population of 
schoolchildren with asthma in a hospital setting and was based on the observation in 
an earlier study that PEF and FEV1, measured at home on this device, rendered lower 
values than both PEF and FEV1 measurements on a pneumotachograph at the 
hospital.16 Therefore, we compared PEF and FEV1 values recorded on a home 
spirometer, with those obtained by the gold standard (on a hospital 
pneumotachograph), both under professional supervision and in a hospital setting.1'2 
Methods 
Children with mild to moderate persistent asthma visiting our outpatient clinic for 
lung function measurements were asked to participate in this study, which was 
approved by the hospital ethics review board. Patients and parents gave written 
informed consent. Children who had respiratory symptoms within 4 weeks before 
the measurements were excluded. The number of participants was based on an 
expected high correlation between the two devices, with a correlation coefficient 
>0.95, and on the objective to apply Bland-Altman plots to assess agreement 
between the two devices. 17 We predetermined the maximum clinically acceptable 
difference between the two measurements at 20 L/min for PEF and at 0.05 L for 
FEV1 with an expected standard deviation of SO L/min for PEF and 0.1 L for FEV1, 
respectively. When using a criterion of significance of 0.05 and a minimum power of 
80%, a total of SO participants was needed.17 
Lung function measurements were performed at our pulmonary function laboratory 
according to ATS guidelines.5 All lung function measurements were supervised by a 
skilled technician who encouraged the children to perform optimal measurements 
on both devices.5 Children were randomized, using Ranstam's block randomization 
into two groups.18 One group performed PEF and FEV1 on the electronic home 
spirometer (Koko Peak Pro) first and then on a Jaeger Masterlab pneumotachograph 
(Erich Jaeger, WOrzburg, Germany); the other group performed measurements in 
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reverse order. A single new home spirometer (serial no. A004692B) was used in all 
measurements.3'5 This is a home spirometer, in vitro validated by using computer­
generated wave-forms which are based on precision and accuracy criteria form the 
ERS/ATS guidelines.5 In both devices, maneuvers were performed in an upright 
position (head and neck remained straight). No computer animations were used. On 
the home spirometer, the best PEF and FEV1 values from three reproducible 
measurements were automatically stored on the device's microchip. The microchip 
data were downloaded to a computer. 
The number of maneuvers needed to obtain these three reproducible 
measurements and the actual PEF and FEV1 values of all maneuvers were recorded 
separately. Both the children and the technician were blinded for the lung function 
values. Using the electronic home spirometer, measurements were regarded as 
being complete when the patient had executed three reproducible maneuvers with 
maximum effort, achieving PEF as rapidly as possible and continuing the maneuver 
for at least 2 sec, all judged by an experienced technician. With the hospital 
pneumotachograph, the best three reproducible flow-volume curves were selected 
by the technician. The number of maneuvers needed to obtain three reproducible 
measurements was recorded. Only the flow-volume curves were visible on the 
hospital spirometer display, not the corresponding PEF and FEV1 values. As a result, 
the children and the technician were also blinded for these lung function values. 
After completing all maneuvers, the best PEF and FEV1 values obtained from the 
three reproducible maneuvers on both the home spirometer and the 
pneumotachograph were judged using international quality criteria for 
reproducibility of maneuver performance (a minimum of three measurement values 
with a maximum difference of 10% or 24 L/min in PEF, whichever is greater, and a 
maximum difference of 5% or 0,1 L in FEV1 measurements, whichever is greater).3'
5 
For both PEF and FEV1, reproducibility was calculated as the difference between the 
highest and the lowest of the three best values as a percentage of the mean value of 
the three best values.5 All data were analyzed using PRISM TM (GraphPad Software, 
San Diego, CA) for Windows™ version 3.00 applying Bland-Altman plotting as 
appropriate.17 
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Results 
Fifty children, aged 6-17 years, with stable mild to moderate persistent asthma 
entered and completed the study. Patient characteristics are shown in table 1. All 
children had performed technically sound and reproducible lung function 
measurements previously at our lung function laboratory. 
All patients performed three reproducible lung function measurements with good 
effort which fulfilled international quality criteria.5 Maneuver reproducibility on the 
home spirometer was 4.5% (95% confidence interval 3.8-5.2%} for PEF and 2.7% 
(95% confidence interval 2.3-3.2%} for FEV1, with a mean difference between the 
highest and lowest of the three best measurements of 1 1.8L/min (95% confidence 
interval 9.9-13.6L/min) for PEF and 0.06L (95% confidence interval 0.05-0.07L} for 
FEV1 . The numbers of maneuvers needed to obtain these three reproducible 
recordings for both devices are shown in table 2. 
Table 1. Patient characteristics 
Sex (M/F) 
Mean age (years) 
Maintenance medication: 
Inhaled corticosteroids 




Positive skin prick test or specific lgE to common 
inhalant allergens 
History of asthma in parent(s) or sibling(s) 
FEV1 hospital spirometer (% predicted FEV1) 
66% versus 34% 








100.7 ± 13.3 
Values are presented as mean ± SD, or as percentage. M: male; F: female; LTRA: leukotriene receptor 
antagonists; FEV1: forced expiratory volume in one second. 
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Table 2. Numbers of maneuvers needed 
Number of maneuvers needed to obtain three 
reproducible measu rements (the three included) 
Pneumotachograph 
4.0 ± 0.9 
Chapter 2 
Home spirometer 
5.6 ± 1.3 
Values are presented as mean ± SD. The mean number of needed maneuvers was significantly 
different between the two devices {95%CI 1.2 to 2.1; p<0.0001). There was no significant difference 
between the randomized groups. 
As expected, both PEF and FEV1 showed a very high correlation between the two 
devices. The correlation coefficient for the PEF measurements between the devices 
was 0.95; for FEV1, it was 0.99. However, PEF recorded on the home spirometer was 
significantly lower than on the hospital spirometer, with a mean difference of 
22L/min (95% confidence interval for difference 14-30L/min; p<0.0001} (table 3}. 
FEV1 was also significantly different between the two devices, but the size of the 
difference was smaller (mean 0.06L; 95% confidence interval for difference 0.02-
0.ll; p<0.05} (table 3}. 
Table 3. Spirometry Data 
Mean ± SD 95%CI 
Home spirometer 
Mean PEF (L/min) 278 ± 78 256-300 
Mean FEVi (L) 2.35 ± 0.75 2.14-2.56 
Pneumotachograph 
Mean PEF (L/min) 300 ± 91 274-326 
Mean FEVi (L) 2.41 ± 0.79 2.19-2.63 
Between devices 
Mean difference in PEF (L/min) 22 ± 29 14-30 
Mean difference in FEV1 (L) 0.06 ± 0.13 0.02-0.10 
Mean spirometry data for the whole study population. PEF: peak expiratory flow; FEV1: forced 
expiratory volume in the first second; SD: standard deviation. 
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Mean FEV 1 = (pneumotachograph + home spirometer)/2 (L) 
mean - 2SD 
Figure lab. Bland-Altman plot of the difference in a) PEF (L/min) and b) FEV1 (L) 
between the home spirometer and the hospital spirometer. The bold line 
represents the mean difference and the dotted lines the 25D of the mean. FEV1 : 
forced expiratory volume in the first second; SD: standard deviation. 
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The Bland-Altman plots show the degree of agreement in PEF (fig. la) and FEV1 (fig. 
lb) between the two devices and the limits of agreement (mean±SD). These limits 
are 80 and -36L/min for PEF and 0.32 and -0.20L for FEV1 and are h igher than the 
predetermined clinically acceptable differences. Nearly 12% of the PEF values 
showed differences greater than SOL/min, and 7% greater than 75L/min between 
the two devices. For FEV1, 19% of the differences between measurements were 
greater than 0.2L and 7% greater than 0.3L. 
Discussion 
Th is study shows that a portable home spirometer can provide reproducible and 
quality acceptable PEF and FEV1 measurements in ch ildren with asthma, but that 
these measurements cannot be interchanged with measurements obtained with a 
pneumotachograph in a lung function laboratory. Both PEF and FEV1 were 
significantly lower on the home spirometer than on the pneumotachograph . The size 
of their difference in PEF was large enough to be clinically relevant (22L/min, 95%CI 
14-30L/min); the size of the difference in FEV1 was smaller (0.06L; 95%CI 0.02-0. lL). 
Although the clinical relevance of the mean difference may be doubtful, several of 
the individual differences clearly were of clinical significance. Differences between 
the two devices in individual patients could be >lOOL/min for PEF and >0.25L for 
FEV1, which are both clinically relevant. This suggests that PEF and FEV1 recorded on 
this home spirometer are not valid proxies for PEF and FEV1 recorded on a 
pneumotachograph in a lung function laboratory setting. It illustrates that even 
home spirometers wh ich comply with ATS measurement criteria in vitro, should be 
validated in the patient group in wh ich the device is to be used. This is in agreement 
with another study wh ich found a clinically relevant difference in the quality of home 
spirometry measurements between populations from two different cities, with no 
suitable explanation.15 
Home monitoring of lung function is considered important in the management of 
ch ildhood asthmaY It has been shown that written PEF diaries are unreliable, 10 and 
the use of home spirometers with electronic data logging have been advocated to 
overcome th is inaccuracy. 11 Studies using electronic home spirometry in childhood 
asthma, however, showed a highly variable relationsh ip between home spirometry 
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measurements and asthma severity.16 In addition, electronic home monitoring of 
lung function did not improve asthma control when compared to symptom-based 
self-management.19 These observations raise the possibility that measurements 
obtained by home spirometry are inaccurate. This was addressed in the present 
study. Although the data in this study were derived from a single home spirometer 
and it may be different for other home spirometers, it is quite likely that any other 
home spirometer will also show a difference with professional 
pneumotachography.12-14 We, therefore, prompt clinicians and researchers to 
examine the differences between measurements obtained on home spirometers 
intended for clinical use and those recorded in the lung function laboratory. 
This home spirometer was validated according to ATS/ERS criteria,5 which were 
revised after this study was undertaken.20 In these revised guidelines, the test 
profiles remained unchanged, but requirement of new test profiles is advocated. 
Nevertheless, one should expect reasonable agreement between measurements 
obtained on any home spirometer and those recorded on a hospital 
pneumotachograph. We were rigorous in standardizing the measurements for both 
devices, strictly following ATS/ERS guidelines for measurement of lung function, 
including those for reproducibility of efforts.5 For both devices, measurements were 
obtained under professional guidance and encouragement, thus eliminating the 
possibility of lower values due to suboptimal patient performance when such 
professional supervision is lacking.3'5 Measurements were made in random order on 
both devices, eliminating bias by a 'learning' effect or by spirometer induced 
bronchoconstriction. Both the technician and the patient were blinded for the lung 
function values obtained. Therefore, the difference found between the two devices 
cannot be explained by different measurement conditions, but appear to be related 
to the device itself. It is likely that the lack of visual feedback on performance with 
the home spirometer used is the most important factor explaining the lower values 
obtained with the home spirometer. Home spirometers with a screen allowing visual 
feedback on the quality of flow-volume loops are being developed, but their 
measurement results have to be compared to a pneumotachograph in vivo. 
In adults, it has been shown that the increased external resistance, associated with 
the measurement technique of a portable peak flow meter reduces PEF by up to 8%, 
when compared to a pneumotachograph.21 This appears to be caused by the fact 
that PEF is reached slightly later in comparison to computer generated wave-
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forms.21 The home spirometer applied in this study measures air flow from the 
shifting of a thin metal plate. This may cause an increased resistance to airflow, the 
size of which remains to be determined. Finally, the lack of (daily) calibration 
possibilities on a home spirometer renders the measurements more susceptible to 
changes in ambient temperature, humidity and air pressure, than a 
pneumotachograph which is calibrated twice daily.5 
Although this study shows that measurements obtained with an electronic home 
spirometer and with a professional pneumotachograph are not interchangeable, this 
does not necessarily render home spirometers useless. Our results clearly show that 
lung function measurements on an electronic home spirometer are highly 
reproducible, at least when performed under professional supervision and 
encouragement. This suggests that home spirometry can be used to calculate diurnal 
variation of lung function, or for tracking changes over time of lung function values 
measured with the same device. 
Our study population consisted of well-controlled asthmatic children and it could be 
argued that the accuracy of home spirometry may be less in symptomatic patients. 
This study shows that reproducibility of PEF and FEV1 measurements was not 
dependent on the level of PEF and FEV1 values. However, because PEF in particular is 
dependent on the effort of the patient, 3 a patient having acute symptoms of asthma 
may have more difficulty to maintain optimal effort with a probably higher number 
of measurements needed than a patient with stable asthma. 
In order to obtain high-quality measurements, home spirometers are equipped with 
quality notifications and incentives, including automatic notification of maneuver 
failure (when the maneuver is too short to measure FEV1, or when PEF is not 
reached within preset limits) and a sound signal during the maneuver, or when it is 
completed. The home spirometer used in this study provides no incentives during 
the forced expiratory maneuvers, but does give a quality notification when PEF is not 
reached within preset limits.3'5 Because both the technician and the patient were 
blinded for the outcome during the measurements, quality control, including 
maneuver reproducibility, had to be applied after completing the whole procedure. 
Even without quality notifications or incentives, the difference between FEV1 on the 
home spirometer and the hospital spirometer measurements was clinically 
acceptable and within the limits set by international guidelines.5 This is in 
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accordance with a previous study showing a h igh number of quality acceptable 
measures at home with no deterioration with in 4 weeks using a similar device.22 
The h igher number of maneuvers needed on the home spirometer to obtain three 
reproducible measurements may show that a certain level of instruction, training, 
and perhaps even encouragement is needed to obtain sufficient reproducible 
measurements for clinical practice. Recently, it has been shown that training and 
education of patients are more important than encouragement to obtain reliable 
and consistent lung function measures using home spirometry over time.15 However, 
we cannot rule out that the higher number of maneuvers on the home spirometer 
are due to the bl inding of the technician and therefore being unsure at what 
moment the three optimal measurements were achieved. All our patients were 
experienced in performing lung function measurements. This may help to explain 
why the difference in measurements obtained by the two devices in our study was 
small. Clearly, ch ildren with asthma should be trained in performing forced 
expiratory maneuvers reliably and reproducibly before embarking on home 
spirometry. Under these circumstances, it has been shown that the quality of lung 
function measurements with home spirometry remains consistent over a period of 3 
months.1s,1s,22 
In conclusion, when ch ildren are well trained to perform forced expiratory 
maneuvers reliably and reproducibly, home spirometry with electronic data logging 
provides a fairly reliable measurement of FEV1 in ch ildren with asthma. However, 
mean PEF and FEV1 values recorded on th is home spirometer are lower than those 
obtained by a hospital pneumotachograph, and individual differences in PEF and 
FEV1 between the two devices may be large. Therefore, home spirometry and 
hospital pneumotachography should not be used interchangeably, because 
differences in the devices, including the lack of visual feedback on smal l  portable 
home spirometers, may significantly influence the results in an important proportion 
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Abstract 
Background 
The usefulness of peak expiratory flow monitoring is disputed because of the 
unreliability of written peak flow diaries. The aim of this study was to examine the 
relationship of peak flow and forced expiratory volume in one second (FEV1) 
variation to other estimates of asthma severity in children, using an electronic home 
spirometer with automatic data storage. 
Methods 
Over a 3-month period, thirty-six children with mild to moderate persistent asthma 
recorded peak flow and FEV1 electronically twice daily and an asthma severity score 
in a written diary. Bronchial responsiveness was assessed at the beginning and 
bronchodilator response and asthma specific quality of life at the end of the study. 
Results 
Peak flow variation correlated significantly, but weakly to bronchial responsiveness 
and bronchodilator response, but not to the asthma severity score or quality of life 
scores. Within individual correlations between asthma severity scores and home 
spirometry indices and between peak flow and FEV1 were highly variable. 
Conclusions 
Peak flow and FEV1 variation obtained by home spirometry show poor concordance 
with other indices of disease activity and with each other. This limits the usefulness 




International guidelines on the management of asthma stress the importance of 
pulmonary function tests to monitor the clinical course of asthma and to achieve 
optimal control.1-3 Measurements of bronchial responsiveness (BR) provide an 
estimate of asthmatic airway inflammatory activity and can be used in monitoring 
childhood asthma.1'3,4 A study in adults has shown that adjusting maintenance 
therapy based on BR measurements improves asthma control and reduces asthmatic 
airway inflammation.4 However, the downside of BR measurements - and of 
pulmonary function tests in general - is that they have to be performed in hospital 
and that they only provide a snapshot impression of asthma status, rather than that 
they reflect the inherent variability of the disease.1-3,5 
This variation of pulmonary function is considered to be one of the key 
characteristics of asthma.1'2 Day-to-day home monitoring of peak expiratory flow 
(PEF) is thought to reflect this variability and is, therefore, recommended in 
guidelines as a monitoring tool.6 Early studies have found a strong correlation 
between PEF variation and BR in adult asthmatics.7'8 However, more recent studies 
have found a weaker relationship between PEF variation and BR in patients treated 
with inhaled corticosteroids.9-12 In all studies on the relationship between PEF 
variation and other indices of asthma severity, l3-ls mechanical PEF meters and 
written PEF diaries were used. Several studies have shown that written PEF diaries 
are unreliable16' 17 and it has been suggested that using electronic home spirometers 
could overcome this drawback.18 Before being able to use electronic home 
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spirometers in a asthma self-management, the usefulness of these instruments in 
accurately reflecting asthma severity should be investigated. Therefore, the present 
study was designed to examine the relationship of home measured PEF and forced 
expiratory volume in one second (FEV1) and their variation, using an electronic home 
spirometer, to other parameters of asthma severity in children with chronic 
persistent asthma. 
Patients and methods 
Patients aged 6 -16 yrs with mild-to-moderate persistent asthma1'2 were recruited at 
the current authors' outpatient clinic ( Princess Amalia Children's Clinic, lsala 
klinieken, Zwolle, the Netherlands). All had been using maintenance therapy with 
inhaled corticosteroids in daily dosages =:;;4Q0µg/day (budesonide, beclomethasone) 
or Q00µg/day (fluticasone) for �6 months and were able to perform pulmonary 
function measurements reproducibly.3'5 Children who had used systemic 
corticosteroids <4 weeks before the start of the study were excluded. Written 
informed consent was obtained from all participants and their parents. The study 
was approved by the hospital ethics review board. 
For characterization purposes, different lung function measurements were 
completed by these patients. Flow-volume-loops were performed on a Jaeger 
Masterlab pneumotachograph (Erich Jaeger, Wurzburg, Germany), following 
ATS/ERS guidelines.3'5 Short-acting bronchodilators and long-acting bronchodilators 
were withdrawn for 8 h and 24 h, respectively, prior to each session. At the start of 
the 3-month study period, the degree of bronchial responsiveness was assessed 
using a methacholine provocation test with the dosimeter method and results were 




19 At the end of the 3-month period the patients performed flow-volume 
loops before and after inhalation of 800µg salbutamol to assess bronchodilator 
response.5 Children aged �7 yrs, and one parent of each patient completed the 
validated Dutch versions of the disease specific Pediatric Asthma (Caregiver's) 
Quality of Life Questionnaire. Responses to these quality of life questionnaires were 






At the first visit patients were instructed how to use the electronic portable 
spirometer (Koko Peak Pro, Ferraris, Louisville, Colorado, USA).5'6 '22 This home 
spirometer has been validated using a precision waveform generator (Pulmonary 
Waveform System; MH Custom Design and Mfg, Midval, UT, USA) demonstrating its 
agreement with performance standards as recommended by international 
guidelines.5 Patients were instructed to perform three forced expiratory flow 
manoeuvres twice daily between 06:00 and 10:00 and between 18:00 and 22:00 
throughout the study period. All instructions were given by the same skilled 
assistant, encouraging the children to obtain optimal lung function values. Patients 
were instructed to expire for �2 seconds and measurements were only accepted if 
forced vital capacity was more than FEV1. The device automatically stored the 
highest of the three correctly performed PEFs on a microchip, along with the 
accompanying FEV1. 
Throughout the 3-month period, patients also recorded a validated asthma severity 
score on a continuous visual analogue scale twice daily in a written diary.23 Score 0 
represented the "worst possible state of their asthma" and score 10 the "sensation 
of having no asthma at all". Children were instructed to first score their perception 
of asthma severity, then perform the forced expiratory flow manoeuvres on their 
home spirometer and finally take their medication. Patients also recorded use of 
rescue bronchodilators in the diary, both as a measure of asthma stability at home 
and to identify and exclude lung-function values influenced by bronchodilator 
medication. In order to identify exacerbations of asthma, patients were instructed to 
return to the clinic if they felt their asthma symptoms could not be controlled with 
rescue bronchodilators. Such exacerbations and use of systemic corticosteroids were 
recorded in the diary. Once a month, data from the home spirometer were 
downloaded to a computer. After careful inspection following a predefined 
algorithm24, recordings due to technical errors and unexplained outliers were 
excluded.22 Adherence to the home recordings was calculated by comparing the 
number of recordings over ~13 weeks (180 recordings minus the technical errors) 
with the number of recordings actually obtained. The PEF and the asthma severity 
score were expressed as percentage of the personal best value {%PB) and the FEV1 
as percentage of the predicted value {%pred).25 Variation of PEF (and of FEV1) was 
expressed in terms of the size of the day's range (amplitude) as a percentage of the 
day's mean (ampl%mean).13 These calculations of diurnal variation were only 
performed in children with an overall adherence with home spirometry of �80%, in 
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order to obtain reliable variation calculations. The Spearman rank correlation 
coefficient was applied as appropriate during data analysis.26 
Results 
In total, 42 children completed the study. The median overall adherence to home 
spirometry and symptom diary keeping was 91.5% and 98.7%, respectively. Six 
ch i ldren were excluded because of an adherence with home spirometry of <80%. 
Technical errors accounted for <10% of the m issing data. Clinical characteristics of 
the remaining 36 children are presented in table 1 and results of home spirometry 
and asthma severity scores in table 2. 




Age of onset of asthma (yrs) 
Maintenance medication: Inhaled corticosteroids (%) 
Short-acting bronchodilators on demand (%) 
Long-acting bronchodilators (%) 
LTRA (%) 
Exacerbations requiring systemic corticosteroids (%) 
Smoking parent(s) (%) 
Positive skin prick test or specific lgE to common inhalant allergens (%) 
History of asthma in parent(s) or sibling(s) (%) 
logPD20-methacholine (µg) 
FEV1 (% pred) 
QOL (children)# 0-7 
QOL (caregiver)1 0-7 
25/11 
10.4 ± 2.5 










99.1 ± 12.6 
6.0 ± 0.81 
6.4 ± 0.48 
Data are presented as mean ± SD, or as median (interquartile range) unless otherwise stated. LTRA: 
leukotriene receptor antagonists; lg: immunoglobin ; PD20-methacholine: dose of methacholine causing 
a 20% fall in forced expiratory volume in one second (FEVi}; %pred: % predicted; QOL: quality of life. #: 
disease-specific QOL of children � 7 yrs old; 11: disease specific QOL of caregivers. 
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Use of rescue salbutamol11 
Asthma severity score (%PB) 
81.4 ± 6.3 
85.5 ± 15.5 
7.9 ± 3.4 
9.5 ± 4.3 
0.5 ± 0.7 
83.4 ± 12.9 
Values are presented as mean ± SD. PEF: peak expiratory flow; %PB: percentage of personal best value; 
FEV1: forced expiratory volume in one second; %pred: percentage predicted; vPEF: variation in PEF; 
ampl/mean: size of day's range as a percentage of the day's mean; vFEV1: variation in FEV1 . 
11: lO0µg 
puffs/day. 
The mean PEF variation (expressed as amplitude/mean) over the 3-month period 
correlated significantly to bronchial responsiveness (Spearman's rank correlation 
coefficient (r5) =-0.43, p=0.009) and to bronchodilator response (expressed as a 
percentage of pre-bronchodilator FEV1; r5=0.34, p=0.04), but the scatter was wide 
(fig. 1). Mean PEF and FEV1 variation did not show significant correlations to the 
asthma severity score, or the patient's quality of life (table 3). 
Table 3. Correlations between home spirometry results and asthma severity measures 
PD20 µg Bronchodilator Pediatric asthma Asthma severity 
response11 QOL score score,i 
PEF (%PB) 
0.35; p=0.04 -0.38; p=0.02 -0.10; p=0.58 0.08; p=0.64 
(0.01 to 0.61) (-0.64 to -0.06} (-0.43 to 0.26) (-0.26 to 0.41) 
FEV1 (%pred) 
0.36; p=0.03 -0.42; p=0.01 0.15; p=0.39 0.06; p=0. 76 
(0.02 to 0.61} (-0.66 to -0.09} (-0.20 to 0.47) (-0.28 to 0.39} 
vPEF (ampl/mean) 
-0.43; p=0.009 0.34; p=0.04 -0.05; p=0.79 -0.15; p=0.39 
(-0.67 to -0.11} (0.00 to 0.61) (-0.39 to 0.31) (-0.46 to 0.20} 
vFEV1 (ampl/mean) 
-0.43; p=0.008 0.14; p=0.41 -0.15; p=0.41 -0.32; p=0.06 
(-0.67 to -0.11) (-0.20 to 0.46) (-0.47 to 0.21} (-0.59 to 0.02) 
Data are presented as Spearman rank correlation coefficient; p-value (95% confidence interval). PD20: 
dose of methacholine causing a 20% fall in forced expiratory volume in one second (FEV1); %PB: 
percentage of personal best value; PEF: peak expiratory flow; %pred: percentage predicted; vPEF: 
variation in PEF; ampl/mean: size of day's range as a percentage of the day's mean; vFEV1: variation in 
FEV1. 
11: percentage of initial FEV1; 'II: %PB. 
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Figure lAB. Correlation of peak expiratory flow (PEF) variation expressed as size 
of day's range as a percentage of the day's mean (ampl/mean) to A) dose of 
methacholine causing a 20% fall in forced expiratory volume in one second (FEV1; 
PD20) and B) bronchodilator response. Although the correlation is significant 
(Spearman's rank correlation coefficient (rs) = -0.43; p=0.009 and rs= 0.34; p=0.04) 
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PEF variation FEV1 PEF FEV 1 variation 
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Figure 2. Distribution plots of individual Spearman's rank correlation coefficient 
correlations (r5; one point per patient) of asthma severity score to peak 
expiratory flow (PEF) variation (expressed as size of day's range as a percentage 
of the day's mean (ampl/mean); • ), forced expiratory volume in one second 
(FEV1; expressed as percentage of predicted value; o), PEF (expressed as 
percentage of personal best; • )  and FEV1 variation (ampl/mean); .1). --: 
median values. 
The correlations between the asthma severity score and home spirometry indices 
were highly variable in individual patients (fig. 2). For example, the individual 
correlation coefficients between asthma severity scores and corresponding FEV1 
values in individual patients ranged from -0.28 to 0.51, with a mean of 0.10. 
Several examples of individual recordings of home spirometer indices and the 
asthma severity score are presented in figure 3. The most striking finding was the 
large variation between and within subjects in the relationships between PEF, FEV1 
and asthma severity scores. Increases in asthma severity scores were accompanied 
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Figure 3. Samples of individual monitoring data showing four different patterns of 
relationships between asthma severity score, forced expiratory volume in one second (FEV1) 
and peak expiratory flow (PEF) variation. A) : concordance of patients ; B) : dissociation or 
chaos; C) : poor perceiver; and D) : excessive symptoms categories. --: asthma severity 
score (percentage of personal best); b.: PEF variation (expressed as size of day's range as a 
percentage of the day's mean (ampl/mean); • :  FEV1 variation (ampl/mean). 
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Figure 4. A) Concordance and B) discordance between measured peak expiratory 
flow (PEF) and accompanying forced expiratory volume in one second (FEV1) in two 
individual patients. 
Based on the association patterns between home spirometry results and asthma 
severity scores, the study group could be divided into four distinguishable patterns; 
reasonable concordance (n=7; 19.5%}, dissociation or chaos (n=9; 25%}, poor 
perceivers (n=13; 36%) and excessive symptoms (n=7; 19 .5%; fig. 3) To the current 
authors' surprise, the concordance of PEF and FEV1 values was highly variable 
between patients with only 67% of the patients showing an acceptable concordance 
(rs >0.5; fig. 4) 
Falls of PEF below 80% or below 60% of personal best values were accompanied by 
highly variable FEV1 values (fig. 5). For example, although the mean FEV1 associated 
with a PEF falling below 60% of the personal best value was 65.8%pred (95% 
confidence interval 63.9 to 67.8 %pred), the spread of FEV1 values associated with 
this drop in PEF ranged from 18-120% of predicted values. 
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Figure 5. Box-and-whisker plots representing distributions of forced expiratory volume in 
one second (FEV1) accompanying peak expiratory flow (PEF) values at 80-100% (n=4060}, 
60-80% (n=2162), and <60% (n=371) of personal best. Data are presented as medians, 
inter-quartile ranges and 90% ranges. * :  minimal and maximal outliers. 
Discussion 
The current study shows that in asthmatic children, the correlation of electronically 
recorded PEF variation to other asthma parameters is too inconsistent to be clinically 
useful. This is not only true for PEF variation expressed as the amplitude as a 
percentage of the day's mean, but also for PEF expressed as a percentage of the 
personal best value and for the variation of FEV1 (table 3). Although the unreliability 
of written PEF diaries is overcome by using an electronic home spirometer, this does 
not improve the poor concordance of PEF variation to other parameters of asthma 
severity. 1 1'1 2'27 The present authors propose that this poor concordance, both 
between and within patients, limits the usefulness of home spirometers in the 
monitoring and management of childhood asthma. 
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It is commonly stated that variation in pulmonary function is one of the key 
characteristics of asthma,1'2 and that PEF variation reflects this variability.6 In the 
present study, the variability of the subjective severity of disease was recorded daily 
using an asthma severity score which has been validated as accurate and 
reproducible.23 Although PEF variation mirrored the variability of the asthma severity 
score in some patients, in most cases there appeared to be no relationship at all. In 
fact, 80% of subjects displayed a (complete) dissociation between indices of home 
spirometry and the asthma severity score (fig. 3). These findings concur with earlier 
studies using mechanical PEF meters.27 Some of these patients may be regarded as 
"poor perceivers" with few symptoms despite considerable variation of PEF and FEV1 
and others as patients with excessive symptoms without any variation of PEF and 
FEV1 .
28 It would be interesting to see if poor perceivers, identified by home 
recordings, could benefit from stepping up therapy, but this study was not designed 
to answer that question. 
Another striking finding of our study was the poor concordance of changes in PEF 
with changes in FEV1, the gold standard of peripheral airways obstruction. Although 
overall correlation between PEF and FEV1 is present and can be expected with 
properly performed manoeuvres, some individual patients show complete 
dissociation between PEF and FEV1 (fig.4). Given the low use of rescue 
bronchodilators in the present study, it is highly unlikely that these findings were 
influenced by bronchodilators used during the day and before measurements.29 
Similarly, falls of PEF below 80% or even below 60% of personal best values, which 
are commonly used as cut-off values for stepping up asthma therapy in self­
management plans, 13 were accompanied by a wide range of drops in FEV1 (fig. 5). 
This illustrates that PEF and FEV1 are not interchangeable parameters of assessing 
airway obstruction.6 FEV1 is less dependent than PEF of the patient's effort and, 
consequently, is a better estimate of smaller airways obstruction.5 Theoretically, 
therefore, monitoring FEV1 could provide a more reliable assessment of airways 
obstruction than PEF. Possibly, the discordance between PEF and FEV1 could, to 
some extent, be explained by FEV1 being a better measure of smaller airway 
obstruction than PEF. In the current study, however, the relationship of FEV1 
variation to other parameters of disease activity was as variable as that of PEF 
variation (table 3). 
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The present findings can probably not be explained by poor accuracy or 
measurement characteristics of the home spirometers, which meet the performance 
standards recommended by international guidelines, both for PEF and for FEV1 .
5 
Although it can be argued that measurements at home are not performed under 
supervision of a skilled assistant, who can encourage the children to obtain optimal 
recordings and who can provide visual feedback of correct performance by 
examining flow-volume loops or by using computer incentives or animations, it has 
been shown that the technical quality of home spirometry recordings in children is 
usually acceptable.30 It is therefore, even more striking that very low FEV1 levels may 
be encountered occasionally in children with chronic persistent, but clinically stable, 
asthma. (fig. 5) It can not be ruled out that some of these very low PEF and FEV1 
values were caused by poor lung function performance and lack of quality control at 
home. Lung function was, on average, normal in patients taking part in the current 
study (table 1). 
Even though there were no exacerbations requiring oral corticosteroids in this study 
group throughout the 3-month period, PEF and FEV1 values were highly variable in a 
number of patients (fig. 3). In such patients, FEV1 values can drop as low as 18% of 
predicted, without being considered as technical errors or unexpected outliers 
according to predefined criteria.24 As, in the context of this study, data recorded on 
the home spirometer were not used in a self-management setting as a basis for 
adjustment of therapy and were only analysed after completion of the 3-month 
study period, these low FEV1 values did not prompt changes in asthma management 
immediately. If they had been used in such a setting, the poor concordance of FEV1 
and PEF (fig. 5) would have complicated self-management considerably. If a drop of 
PEF below 60% of personal best can be accompanied by FEV1 levels ranging from 18-
120% of predicted, it is quite unclear what the best approach to asthma 
management should be. At such a point in time, current self-management strategies 
suggest commencing oral steroids. Although this is logical with accompanying low 
FEV1 levels, giving oral prednisolon to children with an accompanying FEV1 of 
120%pred is clearly inappropriate. Thus, monitoring both FEV1 and PEF can be 
confusing when the changes in these two parameters are discordant. Similar findings 
have previously been described in adults with intermittent or mild persistent 
asthma31, but not in children. The current study shows that such discordance occurs 
in as many as 33% of children with mild-to-moderate persistent asthma. 
62 
Chapter 3 
Asthma is a variable disease and although home spirometry appears to be a reliable 
and intuitively appealing way to monitor pulmonary function in ch ildren daily, the 
current study demonstrates that home spirometry in ch ildren with asthma shows 
highly variable relationships with several distinct measures of asthma severity, 
namely bronchial responsiveness, bronchodilator response, asthma severity scores 
and quality of life. In addition, peak expi ratory flow values, obtained by home 
spirometry, show highly variable concordance to accompanying measurements of 
forced expi ratory volume in one second. The results of the present study may help 
to explain why using an electronic home spirometer in self-management of 
ch ildhood asthma does not appear to be useful in improving asthma control.32 It is 
unlikely, therefore, that home spirometry is going to be useful in the long-term 
monitoring and management of ch ildhood asthma. 
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Abstract 
Background 
In asthma treatment, doses of inhaled corticosteroids are often adapted to 
symptoms and need for bronchodilators. However, in cross-sectional studies in 
emergency room settings, lung function and respiratory symptoms are not always 
concordant. Available longitudinal data are based on written peak flow diaries, 
which are unreliable. Using home spirometry, we studied prospectively whether mild 
respiratory symptoms, prompting reliever therapy are accompanied by a clinically 
relevant drop in lung function in children with asthma. 
Methods 
For 8 weeks, children with asthma scored symptoms and measured PEF and FEV1 on 
a home spirometer twice daily. Additional measurements were recorded when 
respiratory symptoms prompted them to use bronchodilators. Indices of home 
spirometry on symptom free days, days with respiratory symptoms and at times of 
symptoms were compared. 
Results 
50 children (mean age 9.5 yrs, range: 6-15; 31 boys) were included. The mean 
difference between symptom free days and at times of symptoms was 6.6% of 
personal best for PEF (95%CI 3.2 to 10.0; p=0.0004) and 6.0% of predicted for FEV1 
(95%CI 3.0 to 9.0; p=0.0004). There was complete overlap in PEF and FEV1 
distributions between symptom free days and at times of symptoms. The mean 
difference between symptom free days and days with respiratory symptoms was 
3.2% (amplitude as % of mean) for PEF (95%CI 1.2 to 5.3; p=0.002) and 2.4% for FEV1 
(95%CI 0.2 to 4.5; p=0.03). 
Conclusions 
Although statistically significant, the degree of airway narrowing at times of 
respiratory symptoms, prompting the use of reliever therapy, is highly variable 





Assessment of asthma control has become a key issue in current diagnosis and 
management guidelines of the disorder.1'2 This assessment is largely based on the 
patient's perception of acute symptoms and the need for reliever therapy.1'2 Studies 
have shown that many children with asthma as well as their parents are poor 
perceivers of airway obstruction, 3-5 and relying only on the patient's recognition of 
asthmatic symptoms may lead to both overtreatment or undertreatment.4'5 This is 
why monitoring of lung function is advocated in asthma guidelines.1'2 
As peak flow diaries have proven to be unreliable, 6 electronic home spirometers, 
measuring peak expiratory flow (PEF) and forced expiratory volume in one second 
(FEV1), are increasingly being used to assess asthma control and to monitor 
treatment.7-10 Studies have shown variable relationships of diurnal variation of lung 
function to daily symptom scores between children with asthma,7-9 and even poor 
perception of airway narrowing during acute severe exacerbations in the emergency 
room.10 However, whether mild but acute respiratory symptoms in asthmatic 
children at home, prompting them to take reliever medication, are accompanied by 
a measurable degree of bronchial obstruction, remains unclear. This is an important 
issue to clarify because such self-assessment of symptoms and the need for reliever 
medication form the basis of the asthma control scoring systems currently in use, 2 
and are also used in treatment plans using adjustable dosing of asthma therapy.11 
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This study was designed to investigate whether mild respiratory symptoms, 
prompting the use of reliever therapy, are accompanied by a clinically relevant 
change in lung function, and thus whether schoolchildren with well-controlled 
asthma, using inhaled corticosteroids, perceive asthma symptoms adequately, when 
using bronchodilators at home. 
Patients and methods 
Children aged 6 to 16 years with mild to moderate persistent asthma, diagnosed by a 
pediatric pulmonologist, 1'2 and partly or well controlled on maintenance treatment 
with inhaled corticosteroids, were asked to participate in this observational study. 
Children using oral steroids within 4 weeks prior to the study, and those using long 
acting beta 2 agonists were excluded. The study was approved by the hospital ethics 
review board, a certified subsidiary of the Dutch central committee on research 
involving human subjects. All patients and parents provided written informed 
consent. Based on earlier studies, we estimated the average need for 
bronchodilators to be twice a week.8' 12 A study period of 8 weeks was assumed short 
enough to expect a high adherence and long enough to obtain a sufficient number of 
, 8 12 measurements per patient. 
A sample size calculation was performed as follows: in order to be able to detect a 
minimal difference of 5% in PEF (% of personal best; %PB) and FEV1 (% of predicted 
value; %pred) between the daily morning and evening measurements and the 
measurements at time of symptoms that prompted the use of reliever therapy, 
assuming a standard deviation for differences of 10% for both PEF and FEV1,
8 with an 
a of 0.05 and a power of 90%, a total of 44 data pairs were needed. In order to allow 
non-compliance or data errors, we aimed to include SO patients. 
Lung function measurements were performed on a Jaeger Masterlab 
pneumotachograph (Erich Jaeger, Wurzburg, Germany), following ATS/ERS 
guidelines.13 Short-acting bronchodilators were withdrawn for 8 hours prior to each 
session. At the start and at the end of the 8-week study period, patients performed 
flow-volume loops before and after inhalation of 800µg salbutamol to assess 
bronchodilator response. The fraction of nitric oxide in exhaled air (FeNO) was 
72 
Chapter 4 
measured at the start of the study using the portable NIOX MINO device, (Aerocrine, 
Solna, Sweden)14 following international recommendations, 15 and expressed in parts 
per billion (ppb). 
At the first visit patients were instructed how to use the electronic portable 
spirometer ( Koko Peak Pro, Ferraris, Louisville, Colorado, USA).13'16 Th is home 
spirometer has been validated both in vitro by using a precision waveform generator 
(Pulmonary Waveform System; MH Custom Design and Mfg, Midval, UT, USA), 
demonstrating its agreement with performance standards as recommended by 
international guidelines, 13 and in vivo in school-aged children with asthma.17 Patients 
were instructed to perform three forced expiratory flow maneuvers twice daily 
between 6AM and 10AM and between 6PM and 10PM throughout the whole study 
period. In addition, ch ildren were asked to perform the same measurements at the 
moments that symptoms prompted them to take reliever inhalers (at time of 
symptoms). The device automatically stored the h ighest of the three correctly 
performed PEFs on a microchip, along with the accompanying FEV1 . All instructions 
were given by the same experienced technician, encouraging the children to obtain 
optimal lung function values. At least one parent attended the instruction session. 
Patients were instructed to achieve PEF as rapidly as possible and to continue the 
forced expiratory maneuver for at least 2 seconds. An integrated quality check 
warned the user by an exclamation mark when a cough was detected, the blow was 
not long enough, or there was a slow start. Patients were blinded to the measured 
lung function values by blacking out the display of the meter, leaving the 
exclamation mark and the integrated timepiece visible. 
Twice daily throughout the 8-week period, patients scored their asthma symptom 
severity on a validated visual analogue scale in a written diary, 18 ranging from O (the 
"worst possible state of their asthma") to 10 (the "sensation of having no asthma at 
all"). This score was also recorded at time of symptoms prompting the use of reliever 
therapy. Time and date were recorded electronically on the memory ch ip of the 
home spirometer. Children were instructed to always record the asthma severity 
score on the visual analogue scale before performing the forced expiratory flow 
maneuvers on their home spirometer and taking their medication. In order to 
identify exacerbations of asthma, patients were instructed to return to the clinic if 
they felt their asthma symptoms could not be controlled with rescue 
bronchodilators. 
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Data analysis 
After visual inspection following a predefined algorithm, 19 recordings due to 
technical errors and unexplained outliers were excluded. Measurements were only 
accepted for analysis if forced vital capacity exceeded FEV1 . Adherence to the home 
recordings was calculated by comparing the number of recordings expected over 8 
weeks (112 recordings minus technical errors} to the number of recordings actually 
obtained. The PEF and the asthma severity score were expressed as percentage of 
the personal best value (%PB} and the FEV1 as percentage of the predicted value 
(%pred}.20 Variation of PEF and of FEV1 were expressed as the amplitude (maximum­
minimum} as a percentage of the day's mean (ampl%mean}.21 PEF and FEV1 values 
obtained during symptoms were only accepted when the time and date stamp were 
in agreement with the time and date noted in the diary. Assuming that the severity 
of the episodes with symptoms within the individual patient and between patients 
was comparable, a variable number of acute measurements should have no 
influence on analyses and interpretation of the data.22 Asthma severity scores, PEF 
(%PB}, and FEV1 (%pred} obtained on days with respiratory symptoms were 
compared to values during symptom free days, and at time of symptoms. 
Because se lf-management plans generally instruct patients to respond to a single 
drop of a level of lung function below a predetermined cut-off value,2 there was the 
additional need to define such an 'event'. Therefore, the 1.5 SD below mean was 
calculated in each individual patient to identify asthma symptom score events (>1.5 
SD below mean %PB}, PEF events (>1.5 SD below mean %PB}, and FEV1 events (>1.5 
SD below mean %pred} .23'24 This level of lung function reduction has proven to be 
more rigorous than the more commonly used drop to less than 80% personal best 
PEF.23'24 The presence of such asthma severity score events and home spirometry 
events was assessed at times of symptoms, and their concordance was verified. 
Because not all children were expected to experience acute symptoms prompting 
use of reliever therapy, all morning and evening recordings from all children were 
also used to calculate the proportion of asthma severity score events accompanied 
by home spirometry events, as well as the proportion of home spirometry events 
accompanied by asthma severity score events. 
Based on our earlier observation of four distinguishable association patterns 
between asthma severity scores and lung function variation assessed by home 
spirometry, 8 two independent pediatric chest physicians classified the recorded 
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patterns of daily symptom scores, PEF, and FEV1 over t ime as reasonable 
concordance, chaos, poor perception or excessive symptoms. Inter-rater agreement 
was assessed by calculating Cohen's kappa statistic. All data were analyzed using 
PRISM™ (GraphPad Software, San Diego, California, USA) for Windows™ version 
3.00 applying standard parametric and non-parametric tests as appropriate.25 
Results 
A total of 50 patients (31 boys) were included in th is study, with a mean age of 9.5 
(SD 2.2) years. All ch ildren had been using maintenance therapy with inhaled 
corticosteroids in daily dosages up to 400µg/day (budesonide, beclomethasone) or 
up to 200µg/day (fluticasone) for at least 6 months, and short-acting beta 2 agonists 
were used by all patients for relief of acute symptoms. All ch ildren were recruited 
from the population of asthmatic ch ildren followed up at our hospital-based 
pediatric asthma clinic. Three ch ildren (6%) also used leukotriene receptor 
antagonists; none used long-acting beta 2 agonists because th is was an exclusion 
criterion for the study. All were able to perform pulmonary function measurements 
reproducibly. 13 Th irteen ch ildren (26%) were exposed to tobacco smoke at home, 
but all ch ildren denied smoking themselves. Forty ch ildren {80%) were sensitized to 
aero-allergens, mostly house dust mite and pets. Lung function characteristics are 
shown in table 1. 
Table 1. Lung function characteristics of the 50 participating children at the start and the end of 
the study. 
At the start of the study (n=SO) At the end of the study (n=SO) 
FEV1 {% pred) 95.5 ± 12.7 99.6 ± 12.2 
Increase in FEV1 (% pred) 
after 800 µg salbutamol 
4.7 ± 4.3 5.3 ± 4.2 
FVC (% pred) 99.9 ± 11.4 100.2 ± 10.8 
MEF50 (% pred) 94.7 ± 28.2 90.4 ± 26.9 
FeNO (ppb) 18.0 [13.0-25.0] 15 [12.0-26.0] 
Data is presented as mean ± SD or median [ Interquartile range]. FEV1: forced expiratory volume in one 
second expressed as percentage of predicted value; FVC: forced vital capacity expressed as percentage 
of predicted value; MEF50: maximal expiratory flow at 50% of the expiration expressed as percentage of 
predicted value; FeNO: fraction of exhaled nitric oxide expressed as parts per billion. 
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All children completed the study; one symptom diary contained no data so the 
analyses involving symptom scores comprised data from 49 children. During the 8-
week study period, median adherence to home spirometry was 83.9% {Inter-quartile 
range {IQR) 67.0 to 92.0%) and the adherence to keep the symptom diary was 99.1% 
(IQR 96.0 to 100.0%). Less than 10% of non-adherence to home spirometry was 
based on incorrect and therefore unusable measurements. The remainder of the 
missing data was based on forgotten measurements, or measurements outside the 
given time frame. Thirty children {60%) had one or more days with respiratory 
symptoms requiring reliever therapy, comprising a total of 161 days (5.8%). From 
these 161 days, twenty-nine data points (18.0%) were excluded because of 
disagreement in time between the home spirometer and the symptom diary, notes 
in the diary without concurrent measurements or taking reliever therapy before the 
home spirometry measurement was performed. The remaining 132 data points were 
used for analysis. None of the children experienced an asthma exacerbation needing 




100 ... . .. 00 •:::• ·:· ooo � ·:· 00 00° 
0 
... � 0 .... ... :�::o ·=· ooo 0 --,,g,,o-.. 00 .. 
75 � - :• ..... 000 .... 0o 0oo .. 0 . .. % 0 .. ooo ooo 
0 







VAS-score (%PB) PEF (%PB) FEV 1 (%pred) 
Figure 1. Home spirometry and symptom scores: Symptom free days compared to 'at 
times of symptoms'. • :  symptom free days; o : at times of symptoms. VAS: visual 
analogue scale (asthma symptom score) expressed as percentage of personal best 
value; PEF: peak expiratory flow expressed as percentage of personal best value; FEV1 : 
forced expiratory volume in one second expressed as percentage of predicted value. 
Chapter 4 
The symptom diary and home spirometry data comparing symptom free days to at 
times of symptoms are shown in figure 1. The mean difference between symptom 
free days and at times of symptoms was 36.2%PB for asthma severity score (95%CI 
of 29.3 to 43.2, p<0.0001), 6.6%PB for PEF (95%CI 3.2 to 10.0, p=0.0004) and 
6.0%pred for FEV1 (95%CI 3.0 to 9.0, p=0.0004). There was complete overlap in PEF 
and FEV1 distributions between symptom free days and at times of symptoms, 
however (figure 1). While 71% of the times of symptoms prompting reliever therapy 
were identified as asthma severity score events (>1.5 SD below mean%PB), only 
23.9% and 22.9% were scored as PEF events (>1.5 SD below mean%PB} and FEV1 
events (>1.5 SD below mean%pred), respectively. Moreover, the agreement of PEF 
and FEV1 events was variable, as is shown in figure 2. 
Yes Yes Yes 
Yes Yes No 
Yes No Yes 
Yes No No 46.3% 
No No No 
No Yes No 
No No Yes 
No Yes Yes 
VAS PEF FEV, o 10  20 30 40 50 
event event event 
% 
Figure 2. Presence of a fall in symptom score, PEF and/or FEV1 1.5 SD below mean at times 
of symptoms, prompting reliever therapy. Data is presented as the percentage of the total 
number of times with respiratory symptoms prompting reliever therapy. VAS event: visual 
analogue scale (asthma severity score) >1.5 SD below the mean personal best value; PEF 
event: peak expiratory flow >1.5 SD below the mean personal best value; FEV1 event: 
forced expiratory volume in one second >1.5 SD below the mean % predicted value. The 
figure does not add up to a 100% because there were no (reliable) home spirometry 
recordings available with an accompanying absence or presence of an asthma severity 
score event in 2.7% and 3.2 % of the times of symptoms, respectively. 
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Table 2. Mean asthma severity score and variation of lung function (vPEF and vFEV1). 
Symptom free days Days with respiratory Mean difference 
Home spirometry 
(mean ± SD) symptoms (mean ± SD) (95%CI; p-value) 
Mean VAS {% PB) 89.1 ± 14.0 73.1 ± 24.7 15.9 {14.0-17.8; p<0.0001) 
vPEF (ampl%mean) 9.9 ± 10.9 13.2 ± 15.6 3.2 (1.2-5.3; p=0.002) 
vFEV1 (ampl%mean) 9.5 ± 11.3 11.8 ± 16.8 2.4 (0.2-4.5; p=0.03) 
VAS: visual analogue scale (asthma severity score) expressed as percentage of personal best value; 
PEF: peak expiratory flow expressed as percentage of personal best value; FEV1: forced expiratory 
volume in one second expressed as percentage of predicted value. 
Table 2 shows the differences between days with respiratory symptoms and 
symptom free days in asthma severity scores and in the diurnal variation of PEF and 
FEV1, again showing that the decrease in asthma severity scores was much larger 
than the accompanying decrease in PEF and FEV1 on days with respiratory 
symptoms. When examining all morning and evening recordings in all patients in 
more detail, only 19.9% of the PEF events (>1.5 SD below mean%PB) and 16.9% of 
the FEV1 events (>1.5 SD below mean%pred) were accompanied by an asthma 
severity score event (>1.5 SD below mean%PB). Similarly, only 14.6% and 11.4% of 
the asthma severity score events were accompanied by PEF and FEV1 events, 
respectively, and 8.2% of the asthma severity score events were accompanied by a 
combination of a PEF and an FEV1 event. 
We found that the distribution of the four previously described association patterns, 
based on the graphical display of asthma symptoms scores and home spirometry 
recordings, was similar to that of our earlier study in a different patient group.8 The 
two independent pediatric chest physicians only reached a fair agreement in their 
classification, however, with a kappa statistic of 0.37. 
Despite considerable variation in individual patients, mean lung function on the 
home spirometer was comparable at the beginning and the end of the study period, 
with a mean difference in PEF of 0.8%PB (95%CI -4.2% to +2.6) and a mean 
difference in FEV1 of 0.5%pred (95%CI -3.2% to +4.1) between the first and the last 




This study shows that the degree of airway narrowing at times of respiratory 
symptoms, prompting the use of reliever therapy, is highly variable between children 
with asthma. Although mean PEF and FEV1 were significantly lower at time of 
symptoms than on symptom free days, the difference was small (table 2), and the 
distributions of PEF and FEV1 in individual patients showed complete overlap 
between symptom-free days and at time of symptoms (figure 1). Only some 20% of 
the PEF and FEV1 measurements dropped below the predetermined 'event' level, 
while over two-thirds were assessed as asthma symptom score events at the same 
time. In addition, the concordance between PEF and FEV1 events at times of 
symptoms was variable (figure 2). The degree of change in symptom scores at times 
these children decided to use their reliever therapy was much larger than the 
recorded drop in lung function (figure 1). Although this suggests that these children, 
as a group, use their bronchodilators more often than their home spirometry records 
seem to justify, there also was considerable variation between children in the 
relationship between symptom scores and lung function over time. Apparently, 
symptoms and home spirometry evaluate different aspects of asthma which do not 
always concur, and this relationship differs between patients. It proved difficult, 
however, to classify these patterns reliably between different experts. This highly 
variable relationship between symptoms, FEV1 and PEF limits the usefulness of home 
spirometry in childhood asthma, because it remains unclear what change in which 
parameter the patient is expected to respond to, and whether this influences 
clinically relevant outcomes. 
Home or hospital PEF measurements are of limited use because they are dependent 
on the patient's effort and because they mainly reflect large airway caliber instead of 
the increased small airways resistance characteristic of asthma. [4] Electronic 
portable spirometers have the advantage of being able to measure FEV1 which is a 
more sensitive measure of asthma severity than PEF.9' 10 In previous studies, FEV1 
was more likely than PEF to identify a deterioration of lung function that children did 
not report, 9 and to demonstrate increased severity of exacerbations in an 
emergency room setting.1° Conversely, in our study where children recorded PEF 
and FEV1 on symptom-free days and at times of symptoms prompting them to take 
reliever medication, we found a similar variation and decrease in PEF and FEV1 at 
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times of respiratory symptoms. Although the variable concordance between PEF and 
FEV1 at times of respiratory symptoms confirms previous observations that these are 
not interchangeable parameters to measure airways obstruction, 13 the relationship 
between FEV1 and asthma symptoms scores showed the same poor concordance as 
the relationship between PEF and asthma symptoms scores at times of symptoms. 
The approach used closely reflects the use of home spirometry as a monitoring tool 
in outpatients with asthma. Our study, therefore, provides no evidence that home 
spirometry FEV1 measurements are more useful than home spirometry PEF 
measurements for home monitoring purposes. 
Some limitations of the present study need to be discussed. Firstly, the quality of 
data obtained by home spirometry must be considered. Previous studies have 
consistently shown that home spirometry provides reproducible and technically 
reliably results, 26-28 although they are slightly lower than those obtained by hospital 
spirometry. 17 
Secondly, the symptoms that prompted patients to take reliever therapy were not 
specified, and may have included nonspecific complaints such as cough or 
breathlessness. This was a deliberate choice to reflect common clinical practice. In 
theory, different kinds of symptoms may be associated with different degrees of 
airway obstruction but this has never been substantiated. Apparently, asthmatic 
children take reliever therapy as needed, regardless of the nature of the symptoms, 
and this does not always reflect a clinically relevant degree of airway obstruction. 
In addition, the selection of patients in our study needs to be considered. We 
deliberately intended to include patients with stable, well or partly controlled, mild­
to-moderate persistent asthma for a number of reasons. First, this patient profile 
covers the majority of children with asthma in secondary care settings. Most of 
these children, although referred for poorly controlled asthma despite the use of 
inhaled corticosteroids, attain good asthma control 29 and normal levels of lung 
function 30 once they have been educated and trained extensively, and are being 
followed up closely, as has been noticed by others.31'32 Still, these patients 
experience asthmatic symptoms from time to time, prompting the use of reliever 
therapy. It is important to study the reliability of such symptoms, because they form 
the basis of asthma control scoring systems used in clinical guidelines 2 and are being 
used increasingly in treatment strategies of variable dosing of asthma medication. 11 
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Although including patients with more severe, difficult to control asthma, would 
have increased the number of symptom events, this would not necessarily have 
helped to elucidate the relationship between symptoms and lung function at times 
of respiratory symptoms prompting reliever therapy. 
A final limitation concerns the timing of the measurements. Although the asthma 
severity scoring system has been validated as being reproducible and accurate, 18 the 
exact timing of symptom scoring was neither standardized nor controlled. The same 
limitation applies to timing of taking the reliever medication. Therefore, a certain 
degree of discrepancy in timing of symptoms and lung function measurements 
cannot be excluded, and this argues for some caution in interpreting our results. We 
tried to minimize this by clear and explicit instructions to patients and parents and 
by strictly excluding - a relatively large number of - evident disagreements between 
data points from the home spirometry and the symptom diary. In our earlier study, 
participants showed high adherence to home monitoring instructions during a 3-
month study period, and were enthusiastic and eager to record reliable data.8 
In the present study, the patients' own decision to take inhaled bronchodilators was 
used as the moment of assessing asthma severity scores and home spirometry 
recordings. Previous studies examining the relationship between symptoms and 
level of lung function have either been performed in emergency room settings, or 
have analyzed data recorded twice daily at fixed time points, but not at times of 
respiratory symptoms. Our approach was unique, therefore, and it showed that 
patients showed highly variable associations between symptoms scores, PEF, and 
FEV1 at times they felt they needed reliever therapy. It showed that in only 8.0% of 
the times that bronchodilators were used, asthma symptoms, PEF and FEV1 were 
fully concordant. Although a significant change in symptoms scores could be 
expected at times of symptoms, prompting the use of reliever therapy, symptom 
scores did not drop 1.5 SD below mean on more than 25% of occasions when 
bronchodilators were used (figure 2). Because more than one-third of these events 
were accompanied by a home spirometry event, it is unlikely that this was due to a 
too rigorously chosen cut-off value for symptom events. 
In an attempt to identify children with poor symptom perception and excessive 
symptoms, the relationships of asthma symptoms and home spirometry recordings 
in time were assessed. The inter-rater agreement of the classification system used 
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was fair . Although identifying poor perceivers and patients with excessive symptoms 
would be clinically useful and may help to predict functional morbidity of asthma in 
children,9 performing such a classification of patients based on home spirometry and 
symptom records may not be as straightforward and repeatable between observers 
as one might think. Further studies are needed to develop a more robust 
classification system of poor perception and excessive symptoms. Meanwhile, 
clinicians should be aware that the relationship between symptoms of asthma and 
lung function variation over time is highly variable between patients, and can be 
chaotic and erratic in many. As long as it remains unclear to what changes in 
symptom scores, PEF, or FEV1 patients should respond to in which way, home 
spirometry is unlikely to be useful as a monitoring tool in children with asthma using 
inhaled corticosteroids. This is supported by evidence from clinical trials that self­
management plans based on home recordings of lung function, even by electronic 
portable spirometers, is not superior to self-management based on symptoms 
alone.33-35 
To our knowledge, this study is the first to examine the course of home-measured 
PEF and FEV1 longitudinally over time, both on symptom free days and at times of 
acute respiratory symptoms prompting children to take reliever medication, without 
interference or assessment by a healthcare provider. It shows that the degree of 
airway narrowing at times of respiratory symptoms, prompting the use of reliever 
therapy, is highly variable. Classifying children as poor perceivers or as patients with 
excessive symptoms based on graphical display of home recordings of PEF, FEV1, and 
respiratory symptoms proved difficult, with only fair agreement between observers. 
In many children, the association between symptoms and lung function variation on 
a daily basis is chaotic and erratic. These findings limit the usefulness of home 
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Abstract 
Background 
Current reference values for diurnal peak flow variation in healthy children (median 
8.2%; 95th percentile 31%} are so high that considerable overlap exists with 
asthmatic children. These values have been obtained with written peak flow diaries, 
which are unreliable. 
Aim 
To obtain reliable reference values of peak flow variation and forced expiratory 
volume in the 1st second (FEV1} variation in healthy schoolch ildren using home 
spirometry with electronic data storage. 
Methods 
Healthy schoolchildren (n=204; 100 males}, aged 6-16 yrs, measured peak flow and 
FEV1 twice daily for two weeks using an electronic home spirometer. Variation of 
peak flow and FEV1 were calculated as diurnal amplitude as a percentage of the 
day's mean. 
Results 
The mean peak flow variation was 6.2% (95th percentile 12.3%} and mean FEV1 
variation was 5.7% (95th percentile 11.8%}. 
Conclusions 
Using home spirometry with electronic data storage, healthy schoolchildren show 
considerably less peak flow and forced expiratory volume in one second variation 
than previously reported with written peak flow diaries. Being the 95th percentiles of 
the distributions in healthy children, a peak flow variation of 12.3% and a forced 
expiratory volume in one second variation of 11.8% are suggested as cut-off values 




Home monitoring of peak expiratory flow (PEF) is advocated in international 
guidelines for the management of asthma in children and adults.1 Since PEFs are 
highly variable between patients, the patient's personal best value and diurnal 
variation in PEF are used in asthma guidelines, rather than age and sex dependent 
reference values for PEF levels.2-5 Studies have shown a strong correlation between 
airway hyperresponsiveness and diurnal PEF variation in children with asthma.6'7 
Therefore, variation of PEF is considered to be a measure of asthma severity, 1'2 and a 
diurnal variation of PEF of >15-20% is considered increased. There is, however, only 
limited evidence to support this cut-off point.1'2'8'9 The only reference values for PEF 
variation published have been obtained using mechanical PEF-meters with written 
diaries and showed high levels of PEF variation in healthy children, with a median of 
8.2% and a 95th percentile as high as 31%.9 As a result, PEF variation is regarded to 
be of limited use in the diagnosis of asthma in children.1 
More recently, it was shown that recording PEF using written PEF diaries yields 
unreliable data and electronic recording was advocated.10-12 Since the previously 
published PEF variation reference values were obtained using written PEF diaries9, it 
is likely that these are unreliable. Children show high adherence to electronic home 
spirometry and perform these measurements in a technically correct manner.13-15 
The present authors hypothesised that values in records of diurnal variation of lung 
function in healthy schoolchildren obtained by electronic home spirometry would be 
lower than those recorded using unreliable written diaries of measurements from 
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mechanical devices. Therefore, the present study was designed to obtain new 
reference values for PEF variation and forced expiratory volume in one second (FEV1) 
variation in healthy schoolchildren, using such a home spirometer with electronic 
data storage under field conditions. 
Methods 
Healthy peers, aged 6-16 yrs, of children with asthma visiting an outpatient clinic 
(lsala klinieken, Zwolle, the Netherlands), were recruited. Children were excluded if 
they had: 1) a recent or chronic disease of the respiratory tract, or a history of 
chronic respiratory disease; 2) a history of severe respiratory disease e.g. congenital 
lung disease, hospitalization for pneumonia or surgery of the thorax; 3) systemic 
disease with direct or indirect influence on the respiratory tract e.g. neuro-muscular 
disorders; 4) other chronic or acute disease with influence on the respiratory tract; 
5) use of inhaled corticosteroids, bronchodilators or other medicines influencing the 
respiratory tract or 6) household exposure to tobacco smoke.16 
In order to obtain PEF and FEV1 variation data from different age groups and sexes, 
the intention was to include four groups, each of >50 children: males aged 6-11 yrs, 
males aged 12-16 yrs, females aged 6-11 yrs and females aged 12-16 yrs. The total 
number of 200 participants was preset empirically, based on previously published 
normative data studies concerning respiratory disease in childhood.17-20 The age 
groups were formed to represent primary versus secondary schoolchildren. 
At the start of the study, children performed flow-volume curves, in a pulmonary 
function laboratory ( lsala klinieken), using a Jaeger Masterlab pneumotachograph 
(Erich Jaeger, Wurzburg, Germany) following American Thoracic Society 
(ATS)/European Respiratory Society (ERS) guidelines for measuring lung function.5 
Children were excluded if their FEV1 was <80% of the predicted value or the flow­
volume curve had an abnormal shape.5;21 
After inclusion, patients were instructed how to use the electronic home spirometer 
(Koko Peak Pro, Ferraris, Louisville, Colorado, USA).1;5 This portable home spirometer 
has been designed to measure PEF and FEV1 under field conditions without the need 
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for repeated calibration. It has been validated using a precision waveform generator 
demonstrating its agreement with performance standards as recommended by 
international guidelines5;22, as well as in ch ildren with asthma in the same age 
group.23 Patients were instructed to perform three forced expiratory flow 
manoeuvres twice da ily at home between 06:00 and 10:00 and between 18:00 and 
22:00 throughout a 2-week study period. All instructions were given by the same 
experienced technician, encouraging the ch ildren to obta in optimal lung function 
values and at least one parent attended the instruction session. Patients were 
instructed to achieve PEF as rapidly as possible and to continue the manoeuvre for 
�2s. An integrated quality check warned the user when a cough was detected, the 
blow was not long enough, or there was a slow start. The device then showed an 
exclamation mark and ch ildren were asked to repeat their measurements. During 
analyses, measurements were only accepted if forced vital capacity exceeded FEV1 . 
The device automatically stored the highest of the three correctly performed PEF 
measurements on a m icroch ip, along with the accompanying FEV1, labelled with the 
time and date of the measurement. 
Following the 2-week study period, the device was returned and all records were 
downloaded on a computer. Adherence to home spirometry measurements was 
expressed as the percentage of days with two usable recordings (one recording in 
the morning and one in the evening).24 Diurnal variation in PEF (in litres per m inute) 
and in FEV1 (in litres) were expressed as the absolute amplitude (maximum to 
minimum) as a percentage of the day's absolute mean (ampl/mean) and day-to-day 
variation in PEF and FEV1 were expressed as the absolute amplitude (maximum to 
minimum) of the morning measurements as a percentage of their absolute mean 
(ampl/mean).25 
All data were analyzed applying standard parametric and nonparametric tests as 
appropriate.26 The present study was approved by the Medical and Eth ical Judging 
Committee of the lsala klinieken, and study subjects and parents gave written 
informed consent. The reference values for PEF and FEV1 variation obta ined in the 
present population of healthy schoolch ildren were compared to previously 
published results obtained in a sample of asthmatic schoolchildren over a 2-week 
period.14 The home spirometer used, the instructions and procedures of recording 
PEF and FEV1 at home, and the analysis of data were identical between the two 
studies. 
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Results 
Healthy children aged 6-16 yrs (n=205), were included in the present study. After 
inclusion, one child was excluded because of abnormal lung function results and an 
abnormal flow-volume curve (FEV1 <80%pred and curve concavity) at the start of the 
study, despite the absence of respiratory symptoms. Each predefined group 
consisted of �SO children, with a minimum number of 13 children per age year 
group. The characteristics of these groups are shown in table 1. 
Table 1. Characteristics of the four age/sex groups 
Participants n 
Age yrs 




6-11 yr olds 12-16 yr olds 
Female 
51 
8.4 ± 1.7 
105.0 ± 11.9 
98.2 ± 11.1 
90.7 ± 20.3 
Male Female 
50 53 
8.8 ± 1.6 13.8 ± 1.4 
103.9 ± 12.2 106.1 ± 10.9 
98.9 ± 11.1 98.3 ± 11.4 
88.7 ± 18.5 99.7 ± 19.2 
Male 
so 
13.7 ± 1.1 
98.5 ± 11.1 
92.8 ± 10.2 
93.7 ± 20.7 
Data are presented as mean±SD, unless otherwise stated. Pneumo: pneumotachography; % pred: % 
predicted; FEV1: forced expiratory volume in one second; FVC: forced vital capacity; MEFs0: mean 
expiratory flow when 50% of the FVC remains to be exhaled. 
Table 2. Reference values for diurnal variation of peak expiratory flow (PEF) and forced 
expiratory volume in one second (FEV1) using home spirometry with electronic data storage. 
Age/sex groups 
6-11 yr olds 
Female (n=Sl) 
Male (n=S0) 












Amplitude of variation % mean 
PEF FEV1 
95th percentile Mean (95%CI) 95th percentile 
12.3 6.1 (5.4-6.8) 11.8 
10.4 6 .6 (5.8-7.4) 9.8 
12.2 5.2 (4.5-5.9) 8.5 
8.0 5.1 (4.3-6.0) 10.1 
12.3 5.7 (5.4-6.1) 11.8 
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Table 3. Reference values for day-to-day variability of morning peak expiratory flow ( PEF) 
and forced expiratory volume in one second (FEV1) using home spirometry with electronic 
data storage. PEF and FEV1 using home spirometry with electronic data storage. 
Amplitude of variation % mean 
PEF FEV1 
Age/sex groups Mean (95%CI) 95th percentile Mean (95%CI) 95th percentile 
6-11 yr olds 
Female (n=51) 7.3 (6.1-8.4) 12.2 7.1 (5.7-8.7) 13.2 
Male (n=50) 6.8 (6.1-7.6) 11.3 7.0 (6.0-7.9) 1 1.3  
12-16 yr olds 
Female (n=53) 5.8 (5.1-6.5) 8.7 5.3 (4.7-6.0) 8.6 
Male (n=50) 5.2 (4.4-5.9) 9.5 4.8 (3.9-5. 7) 8.7 
Total (n=204) 6.3 (5.8-6.7) 12.2 6.1 (5.5-6.5) 11.3  
Cl: confidence interval. 
The median adherence to home spirometry was 86%, with no significant difference 
between the groups and a small, but statistically significant difference between the 
first and the last week for the total study group (87 vs 82%; p<0.0001). The mean 
diurnal and day-to-day variation (with their 95th percentiles) in PEF and FEV1, 
respectively, are shown in tables 2 and 3. 
Children aged 6-11 yrs exhibited significantly higher variations of PEF 
{95%confidence interval (Cl) for difference 0.9 to 2.5%; p<0.0001) and FEV1 (95%CI 
for difference 0.5 to 2.0%; p=0.002) than children aged 12-16 yrs. There were no 
significant differences in variation of PEF or FEV1 between males and females, nor 
between the first and the last week of measurements. Figure 1 shows the diurnal 
variation of PEF and FEV1 per yr of age and illustrates the slightly decreasing 
variation of PEF with increasing age. 
Both PEF and FEV1 variation were independent of height and weight. Self-reported 
atopy was only present in six children. Exclusion of these six children did not change 
the outcome. None of the children showed a variation in PEF or FEV1 of >20%. The 
overall mean diurnal PEF variation for healthy children aged 6-16 yrs was 6.2% 
{95%CI 5.8 to 6.7%; 95th percentile 12.3%), and the overall mean diurnal FEV1 
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variation was 5.7% (95%CI 5.4 to 6.1%; 95th percentile 11.8%). The mean±SD 
absolute difference between the morning and evening PEF was 18.9±9.0 L/min 
(95%CI 17.7 to 20.2  L/min), and the mean absolute difference between the morning 
and evening FEV1 0.13±0.07 L (95%CI 0.12 to 0.14 L). The diurnal differences 
between the age groups are presented in table 4. Of the healthy children, 76% 
exhibited a lower morning than evening PEFs, suggesting a similar circadian rhythm 
to that seen in asthmatic children.27 However, only 48% of the healthy children 
showed a lower morning than evening FEV1 . 
The previously published asthmatic group consisted of 36 well-controlled asthmatic 
children (25 males) with a mean age of 10.4 yrs.14 In all of the children, the diagnosis 
was confirmed by a paediatric pulmonologist, and all were using maintenance 
treatment with inhaled corticosteroids. Their lung function characteristics are shown 
in table 5. Figure 2 shows the differences in PEF and FEV1 variation between the 
well-controlled asthmatic children of the previously conducted stud/4, and the 
present healthy children. The differences were significant for both diurnal PEF 
variation (p=0.001) and diurnal FEV1 variation (p<0.0001), with mean differences of 
1.4% (95%CI 0.3 to 2.5%) and 2.7% (95%CI 1.6 to 3.8), respectively. There was 
considerable overlap between the healthy children and the well-controlled 
asthmatics for both variables (fig. 2). The range of mean amplitude of diurnal PEF 
variation and diurnal FEV1 variation in the asthmatic group was 3.5-24.3% mean and 
2.8-26.4% mean for PEF and FEV1, respectively, during the first 2 weeks of the study. 
Of the asthmatic children, 24 (62%) showed a diurnal PEF variation of >12.3% or a 
diurnal FEV1 variation >11.8%, the overall 95
th percentile of the healthy group of 
schoolchildren, in any given week of the total 3-month study period. 
Table 4. Mean differences between the morning and evening peak expiratory flow {PEF) and 
forced expiratory volume in one second {FEV1) using home spirometry with electronic data 
storage. 
Age/sex groups PEF L/min FEV1 L 
6-11 yr olds 
Female (n=51) 16.4±5.6 (14.8-18.0} 0.10±0.04 (0.09-0.11} 
Male (n=50} 17.5±7.7 (15.4-19.7} 0.12±0.06 (0.11-0.14) 
12-16 yr olds 
Female (n=53} 23.5±13.0 (19.9-27.1) 0.16±0.08 (0.13-0.18} 
Male yrs (n=50} 18.2±5.8 (16.5-19.8} 0.14±0.09 (0.12-0.17} 
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Figure lAB. Variation in A) peak expiratory flow (PEF) and B) forced expiratory flow in one 
second (FEVi) .  Data are presented as means ( · · · · · :  overall mean). Vertical bars represent the 
95% confidence interval. Variations are reasonably consistent between the different age 
groups, with a trend towards a lower variation of PEF in the older children. Single reference 
values for variation in PEF and in FEV1 are possible. 
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Table 5. Characteristics of the 36 asthmatic children 
logPD20-methacholine (µg) 
FEV 1 (% pred) 
FVC (% pred) 





Data are presented as median (inter-quartile range) or mean±SD, PD20 : provocative dose of 
methacholine causing a 20% fall in forced expiratory volume in one second ( FEVi); %pred: % predicted; 
FVC: forced vital capacity; MEF50: mean expiratory flow when 50% of the FVC remains to be exhaled. 
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Figure 2. Variation of peak expiratory flow (PEF) and forced expiratory flow in one 
second (FEV1 ) in asthmatic (•) and healthy children (o). Horizontal bars represent 
means. Although the means of both groups are significantly different for both PEF 
and FEV1, there is considerable overlap between healthy children and well­
controlled asthmatics. Data for asthmatic children from Brouwer et al.14 
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The present study shows that, using home spirometry, healthy children exhibit 
substantially lower variation of lung function than previously described with 
mechanical PEF meters.9 Since the previously described reference va lues were 
obtained using unreliable written PEF diaries10'1 1, the present study used validated 
home spirometers with electronic data storage, generating more reliable reference 
values of variation of PEF and FEV1 .
12 There were no differences between male and 
female children. Although younger children showed significantly higher variation in 
PEF and FEV1 than older children (table 2; fig. 1), this difference was considered too 
small and too variable to be of clinical relevance. Since PEF and FEV1 variation were 
not dependent upon height or weight, and the influence of age was negligible, all 
data were pooled to give a single reference value of variation of lung function for all 
ages and sexes. Only two (<1%) subjects showed PEF or FEV1 variation of >15%, and 
none of >20%. The day-to-day variability data showed similar results, also lower than 
those previously published9, showing the stability of lung function measurements 
throughout the study. The present authors propose that the 95th percentiles from 
the present study, i.e. 12.3% for PEF variation and 11.8% for FEV1 variation, be used 
as new reference values for diurnal variation of lung function in schoolchildren when 
using home spirometry under field conditions. 
The reference values of PEF and FEV1 variation in healthy schoolchildren were 
significantly lower than those recorded in a group of asthmatic schoolchildren with 
chronic persistent, but clinically stable, asthma (fig. 2). This suggests that home 
spirometry might be a useful diagnostic tool in the differentiation of asthmatic and 
nonasthmatic children. However, it should be emphasised that these results were 
obtained in selected groups of clearly healthy children on the one hand and children 
with a firm diagnosis of chronic persistent asthma who were diagnosed and 
followed- up in a specialised clinic on the other. Whether home spirometry will be a 
useful tool for ruling out or diagnosing asthma in children with nonspecific chronic 
respiratory symptoms remains to be evaluated in a separate study. 
Some limitations of our study need to be discussed. Firstly, our study population was 
not a random population sample. For practical reasons, healthy schoolchildren were 
recruited by asking asthmatic children to approach their healthy peers to participate. 
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By applying strict exclusion criteria, which have proven to be useful in the selection 
of healthy subjects for obtaining lung function reference values16, the present 
selection of healthy children should be representative of healthy nonasthmatic 
children. The application of these strict exclusion criteria precludes examination of 
the influence of passive smoke exposure on the present reference values. In studies 
using mechanical PEF meters and written diaries, diurnal PEF variation was up to 
10% higher in children exposed to tobacco smoke.28 Although this suggests that 
variation of PEF and FEV1 recorded by home spirometry may be higher in healthy 
children of smoking parents than the values reported herein, this should be 
substantiated by further studies. Owing to the low prevalence of atopy in the 
present study cohort, it was not possible to examine its influence on PEF and FEV1 
variation in a meaningful way. 
Secondly, the reference values were obtained using only one type of portable home 
spirometer. It is possible that the use of a different device may have rendered 
different results. It is unlikely, however, that this is clinically relevant. All home 
spirometers are designed for the same purpose, namely measuring lung function 
under field conditions, without the need for repeated calibration. All comply with 
ATS/ERS guidelines and have to be validated using computer-generated waveforms.5 
Although small differences between measurements obtained with home 
spirometers and hospital pneumotachographs have been found23'29-31, manoeuvre 
reproducibility using home spirometry has been shown to be acceptable for a 
reliable calculation of variation in lung function. 13'23 In addition, although there is 
increasing evidence that younger children are able to exhale their complete vital 
capacity in <ls32, the younger children in the present study showed that they could 
perform reliable FEV1 measurements during the instruction sessions, and a 
maximum of only 2 measurements per child were excluded from analyses for this 
reason (data not shown). Furthermore, the children were warned by the device 
during the measurements when a blow was too short and then repeated the 
measurement correctly. Therefore, it is likely that the present reference values for 
PEF and FEV1 variation are also applicable with other home spirometers. Finally, the 
technical quality of the forced expiratory manoeuvre was only checked during the 
instruction session at the start of the study and was not assessed at home. However, 
as mentioned above, a quality check is integrated into the home spirometer, 
warning the user, via an exclamation mark on the screen, if a manoeuvre is 
incorrectly performed. More importantly, other studies have shown that children 
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generate high-quality lung function values with home spirometry under field 
conditions after careful instruction.13' 15 This was also the case in the present study. 
Subjects recorded two usable recordings on >85% of days and showed no 
deterioration of PEF and FEV1 variation over time. Furthermore, these reference 
values will be used in similar circumstances in clinical practice. Therefore, the 
present authors are confident that the reference values obtained for PEF and FEV1 
variation are of high quality and can be used in clinical practice and research. 
To the present authors1 knowledge, the present reference values are the first values 
published for variation in both PEF and FEV1 using home spirometry with electronic 
data storage. Since FEV1 is considered to reflect the patency of intrathoracic airways 
more reliably than PEF and is less effort dependent2'5, FEV1 may well be a more 
useful measure of lung function monitoring in children than PEF. Although 
monitoring lung function at home is advocated in guidelines on the long-term 
management of asthma, studies have consistently shown that such home monitoring 
of lung function and according modification of long-term treatment does not 
improve asthma control or outcome.33-36 As a result, the present authors would not 
encourage the use of the current reference values in asthma self-management. The 
present authors believe, however, that the current study results support the 
hypothesis that home spirometry might be used as a diagnostic tool for childhood 
asthma in children with chronic wheeze, cough, or dyspnoea, when history, physical 
examination and office spirometry are insufficient to make or exclude the diagnosis 
reliably. This hypothesis will have to be tested in a study specifically designed to that 
end. The use of PEF diaries to distinguish asthmatic from nonasthmatic children has 
been largely abandoned as previous studies showed almost complete overlap in PEF 
variation between asthmatic6'7 and healthy children, with a 95th percentile as high as 
31% for PEF variation in healthy children.9 It is now deemed highly likely that these 
reference values were spuriously high because they were obtained using unreliable 
written PEF diaries. If the present reference values for PEF and FEV1 variation are 
compared to levels of such variation in well controlled asthmatic children using an 
electronic home spirometer as monitoring tool, there is much less overlap in 
variation of lung function between healthy children and children with asthma, even 
when the latter were using inhaled corticosteroids.10'13'14 For example, in the 
previously published study of well-controlled asthmatic children using inhaled 
corticosteroids, 62% showed a PEF variation of >12.3% in any given week during a 3-
month study period, using the same home spirometer14, despite (near) normal lung 
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function (table 5). Given the fact that inhaled corticosteroids reduce PEF variation 
considerably6'7, it is highly likely that even more symptomatic asthmatic children will 
show a variation of lung function above the present reference values when they are 
not using inhaled corticosteroids. Prospective studies, however, are needed to 
examine the diagnostic value of home spirometry for the identification of asthma in 
children in whom history and physical examination are insufficiently helpful in ruling 
asthma in or out as the cause of chronic respiratory symptoms. 
In conclusion, the 95th percentiles of variation in peak expiratory flow and forced 
expiratory volume in one second in healthy schoolchildren, using home spirometers 
with electronic data storage, are 12.3% and 11.8%, respectively. This is considerably 
lower than previously reported reference values for peak expiratory flow variation 
obtained using mechanical meters and written diaries, and reduces the amount of 
overlap between healthy and asthmatic children. Further prospective studies are 
required to investigate whether or not home spirometry could be a useful diagnostic 
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Abstract 
Background 
Variation of lung function is considered to be a hallmark of asthma. Although 
guidelines recommend measuring it as a diagnostic tool for asthma, the usefulness 
of this approach has not been studied in children. 
Aim 
To assess the usefulness of home spirometry in children with nonspecific lower 
respiratory tract symptoms, to diagnose or exclude asthma. 
Methods 
In school-aged children, referred by their general practitioner because of chronic 
respiratory symptoms of unknown origin, the diagnosis of asthma was made or 
excluded by a pediatric pulmonologist (gold standard), based on international 
guidelines and a standardized protocol. Additionally, children measured peak 
expiratory flow (PEF) and FEV1 twice daily for 2 weeks on a home spirometer, from 
which diurnal variation was calculated. These results (index test) were not revealed 
to the pediatric pulmonologist. The value of home spirometry to diagnose asthma 
was calculated. 
Results 
61 children (27 boys) were included (mean age:10.4 yrs; range: 6-16 yrs). Between 
asthma and no asthma, the mean difference in PEF variation was 4.4% (95%CI :0.9 to 
7.9;p=0.016) and in FEV1 variation 4.5% (95%Cl:1.6 to 7.4;p=0.003). Sensitivity and 
specificity, based on the 95th-centile of the reference values for PEF and FEV1 
variation (12.3% and 11.8%, respectively) were 50% and 72% for PEF variation and 
45% and 92% for FEV1 variation. The likelihood ratio was 1.8 for PEF and 5.6 for FEV1. 
Conclusions 
The contribution of home spirometry in the diagnostic process for asthma in 




Asthma in children is a clinical diagnosis, and international guidelines recommend to 
use reversibility of bronchial obstruction measured by flow-volume curves to 
establish the diagnosisY Spirometry is particularly indicated if symptoms are 
nonspecific and the diagnosis remains uncertain. 1'2 However, because variation of 
airway obstruction is a hallmark of asthma, most children with asthma will not 
exhibit reversibility at each assessment.3 Therefore, the snap-shot lung function test 
lacks sensitivity.2 Increased diurnal variation of lung function over a period of one to 
two weeks has been proposed as a diagnostic tool for asthma.4 However, population 
studies using portable mechanical peak expiratory flow (PEF) meters, showed 
considerable overlap in PEF variation between healthy and asthmatic children.5 As a 
consequence, the role of measuring diurnal PEF variation as a diagnostic tool for 
asthma in children has diminished.6 Guidelines have been adapted accordingly,1 
although the GINA guideline still considers diurnal PEF variation of additional value 
for the diagnosis and classification of asthma.2 
All original studies on the diagnostic usefulness of PEF variation used mechanical PEF 
meters and written diaries, which have proven to be unreliable.7 Recently, we 
published reference values of PEF and forced expiratory flow in one second (FEV1) 
variation using electronic home spirometry, showing limited overlap between 
healthy and treated, well controlled asthmatic children on inhaled corticosteroids.8 
From earlier studies, we know that PEF variation decreases significantly during the 
first two months of treatment with inhaled corticosteroids.9 This suggests that the 
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difference in diurnal PEF and FEV1 variation between not yet diagnosed -untreated­
children with asthma and non-asthmatic children may be larger than previously 
thought, and that home spirometry could be a diagnostic tool for asthma when 
symptoms are nonspecific. To test th is hypothesis, we studied the usefulness of 
home spirometry in diagnosing asthma in school-aged children referred for 
evaluation of nonspecific lower respiratory tract symptoms. 
Patients and Methods 
This study was set up to evaluate the diagnostic value of home spirometry in 
children with nonspecific respiratory symptoms, such as cough and breathlessness, 
in whom the general practitioner was uncertain about the diagnosis of asthma. 
Consecutive ch ildren, 6 to 16 years of age, referred to our hospital-based pediatric 
asthma clinic because of chronic respiratory symptoms of unknown origin were 
asked to participate in this study. The following children were excluded: children 
with a straightforward diagnosis of asthma based on classical respiratory symptoms, 
children referred because of poorly controlled asthma and children with reported 
use of systemic corticosteroids or long-acting beta-2-agonists with in four weeks 
prior to the referral date. This study was approved by the hospital eth ics review 
board, a certified subsidiary of the Dutch central committee on research involving 
human subjects. 
Based on earlier studies, a period of 2 weeks of home spirometry measurements was 
chosen because th is is sufficient to show increased lung function variation in children 
with untreated asthma,4 and adherence to home spirometry is high.10'11 A sample 
size calculation was performed as follows: for PEF and FEV1 variation, we anticipated 
a standard deviation of 3.5%, equal for both groups.11 In order to be able to detect a 
minimal difference of 4% in PEF and FEV1 variation between an asthma and a no 
asthma group -with an a of 0.05 and a power of 90%-, 18 data pairs were needed. 
We estimated that in approximately 60% of the referred patients the diagnosis of 
asthma would be made; therefore, including 45 patients would suffice. In order to 
allow non-compliance or data errors, we aimed to include 60 patients. 
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After obtaining written informed consent from patients and parents, children were 
included and if applicable, inhaled corticosteroids (ICS) were withdrawn. Fourteen 
days later, at a first visit to our asthma clinic, a semi-structured medical history was 
taken and physical examination was performed by a pediatric pulmonologist. The 
fraction of exhaled nitric oxide (FeNO) was measured using a portable NO-meter 
(NIOX MINO, Aerocrine, Solna, Sweden)12 according to international 
recommendations, 13 and expressed in parts per billion (ppb). Subsequently, patients 
performed flow-volume loops before and 20 minutes after inhalation of 800µg 
salbutamol. All lung function measurements were performed on a Jaeger Masterlab 
pneumotachograph (Erich Jaeger, Wurzburg, Germany), following ATS/ERS 
guidelines, 14 and short-acting bronchodilators were withdrawn for 8 hours prior to 
each lung function session. At the second study visit 2 weeks later, history, physical 
examination and FeNO measurements were repeated, and bronchial responsiveness 
was assessed by methacholine provocation using the dosimeter method.15'16 Results 
were expressed as the provocative dose of methacholine causing a 20% fall in FEV1 
(PD20) .  During the 2-week study period, only short acting bronchodilators when 
needed were allowed, and children were instructed to return to our clinic 
immediately if symptoms remained uncontrolled. 
During the 2-week study period between the two study visits, children measured PEF 
and FEV1 twice daily on a home spirometer (index test). These results were not 
revealed to the pediatric pulmonologist at any time during the study. During the first 
visit, patients were instructed carefully how to use the electronic portable 
spirometer (Koko Peak Pro, Ferraris, Louisville, Colorado, USA).14'17 
This home spirometer has been validated both in vitro by using a precision 
waveform generator (Pulmonary Waveform System; MH Custom Design and Mfg, 
Midval, UT, USA) demonstrating its agreement with performance standards as 
recommended by international guidelines, 14 and in vivo in schoolchildren with 
asthma. 18 Patients were instructed to perform three forced expiratory flow 
manoeuvres twice daily between 6AM and 10AM and between 6PM and 10PM 
throughout the whole study period of 2 weeks. The device automatically stored the 
highest of the three correctly performed PEFs on a microchip, along with the 
accompanying FEV1 . All instructions were given by the same experienced technician, 
encouraging the children to obtain optimal lung function values. At least one parent 
attended the instruction session. Patients were instructed to achieve PEF as rapidly 
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as possible and to continue the forced expiratory manoeuvre for at least 2 seconds. 
An integrated quality check warned the user by an exclamation mark when a cough 
was detected, the blow was not long enough, or there was a slow start. After careful 
inspection following a predefined algorithm, 19 recordings due to technical errors and 
unexplained outliers were excluded. During analyses, measurements were only 
accepted if forced vital capacity exceeded FEV1 and recordings were performed 
within the given time frame. 
Adherence to home spirometry was calculated by comparing the number of 
recordings expected over 2 weeks with the number of recordings actually obtained. 
The PEF was expressed as percentage of the personal best value (%PB) and the FEV1 
as percentage of the predicted value (%pred).20 Variation of PEF (and of FEV1) was 
expressed as the amplitude (maximum-minimum) as a percentage of the day's mean 
(ampl%mean).21 
At the second visit and after reviewing history, physical examination and lung 
function data, but without the home spirometry results (index test), a single 
experienced pediatric pulmonologist made or excluded the diagnosis of asthma in 
each patient (gold standard). When asthma was excluded the differential diagnosis 
was evaluated and further appropriate testing was performed - if necessary - until 
the diagnosis was reached. 
The gold standard (asthma diagnosis by the pediatric pulmonologist) and the index 
test (PEF or FEV1 variation by home spirometry) were compared, and test 
characteristics were calculated by using the 95th-centile for PEF and FEV1 variation in 
healthy schoolchildren, 12.3% and 11.8% respectively, as the cut-off between 
normal and increased PEF or FEV1 variation.
8 Receiver operating characteristic (ROC) 
curves for PEF and FEV1 variation were produced to assess the diagnostic 
performance of the index test. Data were analyzed using PRISM TM (Graph Pad 




Sixty-one children (27 boys) were included in th is study, with a mean age of 10.4 
years (range: 6-16 years). At inclusion, ch ildren had experienced nonspecific 
symptoms of recurrent wheeze or cough and breathlessness for at least three 
months, reported as partly relieved by bronchodilators. All ch ildren were able to 
perform pulmonary function measurements reproducibly. All ch ildren completed the 
study. 
In 21 ch ildren (34%) asthma was diagnosed (asthma group). The remaining 40 
children (64%) comprised the no asthma group and were diagnosed as follows: 13 
children (33%) (allergic) rh initis, treated successfully with nasal corticosteroids, 13 
(33%) dysfunctional breathing, defined as chronic or recurrent changes in breath ing 
pattern, causing respiratory and non-respiratory complaints, 22 which was confirmed 
and treated successfully by a physiotherapist, eight (20%) recurrent upper 
Table 1. Distribution of patient characteristics between the asthma and no asthma group. 
Diagnosis No asthma (n=40) Asthma (n=21) p-value 
Mean age (yrs) 10.5 ± 2.5 10.2 ± 2.7 0.690 
Sex: (%male) 17 (43%) 10 (48%) 0.702 
Family history of asthma(lst degree) 23 (58%) 16 (76%) 0.149 
Symptoms: Wheeze 11 (28%) 18 (86%) <0.0001 
Cough 22 (55%) 15 (71%) 0.212 
Breathlessness 40 (100%) 21 (100%) 1.000 
Smoking: Parent(s) 12 (30%) 5 (24%) 0.608 
Patient 0 (0%) 1 (5%) 0.164 
Sensitization: No sensitization 22 (55%) 1 (5%) <0.0001 
Only aero allergens 15 (37%) 17 (80%) 0.001 
Only food allergens 1 (3%) 1 (5%) 0.637 
Both 2 (5%) 2 (10%) 0.498 
Medication: No inhaled medication 7 (17%) 0 (0%) 0.042 
SABA* only 12 (30%) 6 (29%) 0.907 
ICS
t 
21 (53%) 15 (72%) 0.213 
Other asthma drugs 
• short-acting beta-2-agonists; tinhaled corticosteroids. 
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respiratory tract infections, two (5%) serologically proven pertussis, three {7%) 
chronic persistent cough. In addition, there was one patient (3%), who, after further 
diagnostic work-up including body plethysmography a nd diffusion capacity 
measurements, appeared to have a restrictive lung function deficit, for which the 
underlying cause could not be determined. Asthma was excluded in this patient by 
the absence of wheeze, even while symptomatic, absence of bronchodilator and 
methacholine responsiveness, and normal FeNO values. Patient characteristics in the 
two groups are shown in table 1, and lung function results in table 2. 
Table 2. Lung function characteristics of the 61 participating children showing statistically 
significant differences. 
Diagnosis 
1st visit FEV1 (% pred) 
Increase in FEV1 {% pred) 
after 800 µg salbutamol 
1st visit FVC {% pred) t 
1st visit FEV1/FVC {%pred) 
1st visit MEF50 (% pred) :t: 
1st visit FeNO (ppb) § 
2nd visit FEV1 (% pred) 








101.1 ± 11.3 
3.5 ± 4.1 
100.1 ± 11.5 
101.3 ± 6.5 
83.2 ± 16.5 
28.5 ± 26.6 
101.0 ± 11.5 
32.2 ± 27.9 
3.15 [2.71 - 3.15] 
84.0 ± 8.3 




86.4 ± 15.2 7.8 - 21.8; <0.0001 
11.7 ± 6.0 5.5 - 10.9; <0.0001 
91.8 ± 13.8 1.7 - 15.1; 0.0153 
94.0 ± 11.1 2.4 - 11.5; 0.0035 
62.3 ± 20.4 11.1 - 30.7; <0.0001 
72.8 ± 39.1 26.6 - 62.0; <0.0001 
85.4 ± 19.5  4 .2  - 15.6; 0.0005 
67.1 ± 41.5 15.5 - 54.2; 0.0007 
1.83 [1.61 - 2.31] 0.8 - 1.3; <0.0001 
76.9 ± 13.9 1.1 - 13.0; 0.0203 
75.5 ± 18.5 5.1 - 22.5; 0.0024 
Values are presented as mean ± SD, or as median and inter-quartile range for PD20, forced expiratory 
volume in one second expressed as percentage of predicted value; tforced vital capacity; *maximal 
expiratory flow at 50% of expired volume; §fraction of exhaled nitric oxide expressed in parts per 
billion; 1 1provocative dose of methacholine causing a 20% fall in FEV1; 1peak expiratory flow expressed as 
percentage of the personal best value. 
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Home spirometry data from two patients (one with asthma and one with no asthma) 
were lost due to battery failure of the device. There were no other technical errors. 
For the remaining 59 patients, mean adherence to home spirometry during the 2-
week study period was 93% (SD 8.8%), and this was comparable in the asthma and 
no asthma group (mean difference 0.1%, 95%CI -4.9% to 4.7%; p=0.98). Figure 1 
shows the distributions of PEF and FEV1 variation in the asthma and the no asthma 
groups. The mean differences in PEF variation and FEV1 variation between the two 
groups were 4.4% (95%CI 0.9 to 7.9; p=0.016) and 4.5% (95%CI 1.6 to 7.4; p=0.003), 
respectively. Test characteristics of increased PEF and FEV1 variation for the 
diagnosis of asthma, using the 9Sth-centile of the reference values for PEF and FEV1 








































·:· .... . .. ·,::· 
:::;:-·:• 
No asthma 
Figure 1. Distributions of PEF and FEV1 variation in the asthma and the no asthma 
group showing complete overlap for both home spirometry indices between the two 
groups. o : PEF variation. • :  FEV1 variation. Lines represent median values. 
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Table 3. Test characteristics calculated when the 95t -centile of the reference values for PEF and 
FEV1 are used. 
PEF* variation ::!:: 12.3% FEV/ variation s 11.8% 
Sensitivity {95%CI) 0.50 (0.30 to 0.70) 0.45 (0.25 to 0.67) 
Specificity {95%CI) 0.72 (0.56 to 0.84) 0.92 (0.80 to 0.97) 
Positive predictive value (95%CI) 0.48 (0.28 to 0.68) 0.75 (0.47 to 0.91) 
Negative predictive value {95%CI) 0.74 (0.58 to 0.85) 0.77 (0.63 to 0.86) 
Likelihood ratio {95%CI) 1.77 (0.91 to 3.45) 5.85 { 1.78 to 19.24) 
• peak expiratory flow; tforced expiratory volume in one second. 
Receiver-operating cha racteristic {ROC) curves for PEF and FEV1 variation a re shown 
in figures 2A and 2B, respectively. The a rea under the curve (AUC) is 0.69 for PEF 
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PEF variation 0.0 FEV1 variation 0.00 0.25 0.50 0.75 1 .00 0.00 025 0.50 0.75 
False positive rate (1-specificity) False positive rate (1-specificity) 
B 
Figure 2. Receiver operating characteristics curves for A) PEF variation and B) FEV1 
variation showing the poor diagnostic performance of both home spirometry 
indices. Area under the curve (AUC) for PEF variation: 0.69; AUC for FEV1 variation: 
0.77. Numbers in the graphs represent the associated cut-off values for PEF and 




Th is study shows that the diagnostic value of home spirometry in making or 
excluding the diagnosis of asthma in schoolch ildren with nonspecific respiratory 
symptoms, such as cough and breathlessness, is limited. Although mean variation of 
PEF and FEV1 using home spi rometry were significantly lower in the no asthma group 
than in the asthma group, the difference was small, and the distributions of PEF and 
FEV1 variation showed complete overlap between the two groups (figure 1). Home 
spirometry contributed marginally to the likelihood of asthma, with likelihood ratios 
of 1.77 and 5.85 for PEF and FEV1 variation, respectively. The receiver operating 
characteristic curves (figure 2) illustrate the poor diagnostic performance of PEF and 
FEV1 variation using home spirometry in schoolch ildren with chronic nonspecific 
respiratory symptoms. 
A well-recognized difficulty in the diagnosis of asthma in ch ildren is the lack of one 
reliable diagnostic test, in particular when symptoms are nonspecific. Asthma is a 
clinical diagnosis based on multiple key indicators increasing the probability of the 
presence of the disease.1'2 Wheezing is considered a key symptom in asthma, but 
because patients and parents vary considerably in their interpretation of 'wheeze' 
(which may include any kind of noisy or difficult breathing),23'24 the presence of 
expiratory wheeze, as a sign for the presence of airflow obstruction, should be 
confirmed by a health care professional, either by physical examination or by lung 
function testing.2'24'25 Th is is corroborated by the results of our study, in wh ich a 
history of wheezing, although more common in the asthma group, was also present 
in a quarter of the patients in the no asthma group. (table 1) 
Because we aimed to assess the diagnostic value of home spirometry in ch ildren 
with nonspecific respiratory symptoms specifically, we excluded ch ildren with a 
straightforward diagnosis of asthma based on classical respiratory symptoms. The 
main reason for th is approach was that home spi rometry would not have to be used 
in such patients to confi rm the diagnosis of asthma. In clinical practice, an 
assessment of lung function variation is primarily used to help making or rejecting 
the diagnosis of asthma in patients in whom history and physical examination alone 
are insufficient to make or reject the diagnosis. Th is study was designed to test the 
usefulness of home spirometry in exactly that clinical population. Ch ildren referred 
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because of poorly controlled asthma were excluded because of the increased 
exacerbation risk after the withdrawal of inhaled corticosteroids. 
Guidelines recommend additional lung function tests to establish the diagnosis, 1 or 
increase its likelihood.2 In this study, we used FeNO, lung function, bronchodilator 
response and bronchial hyperresponsiveness to help making or rejecting the 
diagnosis of asthma in schoolchildren experiencing nonspecific respiratory 
symptoms. By combining the results of these tests and the suspected presence of 
asthma based on the semi-structured medical history and the physical examination, 
we assured that the diagnosis of asthma was made reliably and according to 
international guidelines.1-2 As a result of this study design, the diagnostic properties 
of each of the separate tests which were used to make the diagnosis can not be 
reported. Home spirometry did not emerge as a reliable diagnostic test for asthma in 
children with nonspecific respiratory symptoms. 
The likelihood ratio of a test represents the change in disease probability after 
performing the test.26 With a pre-test probability of asthma of 34% in our study 
population, the likelihood ratio of 1.77 for PEF variation leads to a post-test disease 
probability of approximately 44%. Such a small increase in disease likelihood 
underscores the poor diagnostic value of PEF variation in the diagnosis of 
asthma.26'27 The likelihood ratio of 5.85 for FEV1 variation increases the post-test 
disease probability considerably to approximately 73%, mainly because the 
specificity of increased FEV1 variation is larger than that of PEF variation (table 3). 
However, the sensitivity of increased FEV1 variation was poor, identifying less than 
half of the asthmatics in the present study (table 3, figure 1). The receiver operating 
characteristic curve of FEV1 variation (figure 2B) shows that the false positive rate 
rises quickly when lower cut-off values of FEV1 variation are used to increase 
sensitivity. In addition, the large degree of overlap in FEV1 variation between the 
asthma and no asthma group (figure 1) limits its usefulness in individual patient care. 
Therefore, despite the reasonable likelihood ratio, the applicability of FEV1 variation 
as a diagnostic test for asthma in children with nonspecific respiratory symptoms is 
limited. 
Some limitations of the present study need to be discussed. Firstly, the quality of 
data obtained by home spirometry must be considered. Previous studies have 
consistently shown that home spirometry provides reproducible and technically 
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reliably results, 27-29 although they are slightly lower than those obtained by hospital 
spirometry.18 
Secondly, like earlier diagnostic studies in childhood asthma,4•30 this study was 
powered to detect a minimal difference between two groups, but not to establish 
agreement between two tests (gold standard and index test). Although adequately 
sized groups were formed and the expected minimal difference of 4% was found, 
establishing agreement between two clinical tests would have taken at least SO data 
pairs.31 With only 34% of the referred children receiving a diagnosis of asthma, a 
total of 150 inclusions would have been necessary. Nevertheless, the complete 
overlap in distributions of PEF and FEV1 variation between the asthma and no 
asthma group (figure 1) makes it unlikely that increasing the sample size of our study 
would have changed its results in a clinically relevant way. 
In conclusion, this study shows that the usefulness of home spirometry in the 
diagnostic process of asthma in children with nonspecific respiratory symptoms is 
limited. Even if obtained by electronic home spirometry, PEF and FEV1 variation 
should not be used as a diagnostic tool for asthma in children with nonspecific 
chronic respiratory symptoms. 
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Genera l discussion 




The general aim of this thesis was to explore the usefulness of electronic home 
spirometry measuring lung function variation in monitoring disease severity in 
childhood asthma and in making the diagnosis of asthma in children. The foundation 
of this thesis was provided by the study by Kamps et al, showing the unreliability of 
written peak expiratory flow (PEF) diaries in childhood asthma (figure 1).1'2 Because 
the disadvantage of unreliable written paper PEF diaries does not apply to electronic 










Week 1 Week 2 
• Redline et al □Kamps et al 
Week 3 
Figure 1. Summary of results of two 
studies examining adherence to PEF 
diary keeping in children with asthma. 
In both studies, children were unaware 
that their PEF diary adherence was 
being monitored. Bars represent the 
percentage of values missing from the 
electronic diary but recorded in the 
written diary during the first three 
weeks of PEF monitoring. Black bars, 
black inner city children,37 white bars, 
white children from affluent families.1 
Reproduced with permission from 
Kamps et al.2 
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alternative for monitoring the severity of asthma in children.3,4 Although intuitively 
appealing, the usefulness of home spirometry in the follow-up of childhood asthma 
is supported by little evidence. 
Earl ier studies, using written PEF diaries, showed a weak correlation between lung 
function variation and other parameters of asthma severity.5-7 However, the 
correlation between asthma severity and home measured peak flow variation 
assessed by home spirometry was unknown. The studies in this thesis show that the 
usefulness of home spirometry in ch ildhood asthma, whether for monitoring disease 
severity or for making the diagnosis of asthma, is limited (chapters 3J 4 and 6}. Based 
on these results, we recommend that international guidelines be adapted. Presently, 
the use of home spirometry to monitor childhood asthma can not be recommended. 
Consequently, alternative methods should be studied to monitor the day-to-day 
variation of the disease. 
Validation of the home spirometer and quality of the 
measurements 
All studies presented in th is thesis used the same kind of electronic portable 
spirometer (Koko Peak Pro, Ferraris, Louisville, Colorado, USA; figure 2). This home 
spirometer has been validated using a precision waveform generator (Pulmonary 
Waveform System; MH Custom Design and Mfg, Midval, UT, USA) demonstrating its 
agreement with performance standards as recommended by international 
guidelines.8 The device is relatively low-cost (approximately € 40) and easy to handle 
for both patient and clinician. It is accompanied by simple software and can be 
linked directly to a computer by an infra-red connection in a cradle (figure 2). 
The device measures both PEF and FEV1, without the need for regular calibrations. 
We found that the home spirometer yielded reproducible and quality acceptable PEF 
and FEV1 measurements. Although they were significantly lower than results 
obtained by hospital spirometry, and they can not be used interchangeably with 
office-based spirometry measurements, PEF and FEV1 measured by home spirometry 
are suitable to assess diurnal peak flow and FEV1 variation, and to assess actual peak 
flow and FEV1 values prospectively (chapter 2). Therefore, the electronic home 
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Figure 2. Koko peak pro 
in a cradle, the docking 
station, with an infra-red 
connection to download 
and process data. 
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spirometer is a useful device for home recording of lung function under field 
conditions. 
Adherence to home spirometry 
The high adherence observed in all studies in this thesis suggests that children are 
more willing to record lung function electronically on a home spirometer than to 
record values on a mechanical peak flow meter.1 This difference is possibly caused 
by the novelty and attractiveness of the electronic device, but in the context of the 
studies it may also be due to the fact that the children and their parents were aware 
that missing values would be noticed. Although overall adherence in the studies was 
very high, it is still considerably lower than the adherence reported in adults using an 
electronic peak flow device in a similar research setting.9 Whilst the adherence to 
home spirometry in adults decreased slowly from 96% in the first eight weeks to 
89% after a total of 72 weeks, 9 the adherence of children in our studies decreased 
more rapidly from approximately 95% in the first two weeks to nearly 90% after only 
13 weeks (chapters 3 and 6}. In addition, in the healthy school children (chapter 5) 
the adherence during 2 weeks of home spirometry was only 86%, possibly due to the 
fact that they and their parents were not used to examine their health status daily. 
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Furthermore, in the children with asthma who were instructed to measure lung 
function also at time of symptoms (chapter 4), after 8 weeks the median adherence 
dropped below 85%. This suggests that children are initially as adherent to home 
spirometry as adults, but they lose their motivation more rapidly. Apparently, the 
novelty and attractiveness of the home spirometer wear off rapidly for children. This 
undermines the usefulness of long-term home spirometry in children. All children 
were surprisingly loyal in keeping the simple symptom diaries during the relevant 
studies (chapters 3 and 4). The straightforwardness and the single item per sequence 
to address may have enhanced the adherence to the symptom diary.10 However, 
because the reliability of the symptom diaries could not be verified, its results should 
be interpreted cautiously.11 
Technica l  errors 
Approximately 1% of the registrations from the home spirometer were useless as a 
result of technical errors including tampering with the device (figure 3), use by family 
members and friends, and battery failure. Due to the natural curiosity of children, 
such technical errors are - to some degree - unavoidable, 12 and have shown to be 
present in similar proportions in various other devices.13'14 Although such technical 
errors are easily recognizable, recorded data must be thoroughly and manually 
scrutinised before they can be interpreted, thus limiting the appealing 'plug and 





·c. 400 >< 
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Figure 3. Tampering with the device by pushing the metal plate behind the 
mouth peace manually and producing spuriously high peak flows. 
Technical qual ity 
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One potential limitation of all studies performed as part of this thesis, is the 
technical quality of lung function measurements in home spirometry. At home, 
measurements are not performed under supervision of a skilled lung function 
technician, who can encourage a child to obtain optimal recordings by using 
computer incentives or animations (chapters 3A5 and 6). Furthermore, the device 
used in our studies does not provide visual feedback of correct performance, and 
does not record flow-volume loops for visual inspection and quality control. Previous 
studies have shown, however, that the technical quality of home spirometry 
recordings in children is usually acceptable.13 Additionally, the home spirometer 
used in this thesis had an integrated quality check, warning the user, by an 
exclamation mark on the screen, when a cough was detected, the blow was not long 
enough, or the start of the expiratory manoeuvre was too slow.15'16 In the event of 
such a warning, children were instructed to repeat the measurements immediately 
and the device would erase the incorrectly obtained values from the microchip. 
During analyses, outliers, remaining measurements with an attached warning, and 
measurements with an FEV1 not exceeding the accompanying FVC, were deleted to 
optimize the quality of the data (chapters 3,4,5 and 6}. We are therefore confident 
that the data obtained by home spirometry in this thesis were technically acceptable 
and valid. 
Another potential limitation concerning the reliability of the measurements is the 




However, given the low use of rescue bronchodilators in the studies presented, and 
the recording of the timing of their use, it is highly unlikely that the findings were 
influenced by bronchodilators used during the day and before measurements.18 
When compared to hospital pneumotachography, we found an acceptable 
manoeuvre reproducibility showing the consistency of measurements on the device 
(chapter 2). However, peak flow, and FEV1 to a smaller extent, was significantly 
lower on the home spirometer than values obtained from hospital 
pneumotachography (table 1), excluding home spirometry as a valid proxy for 
clinical spirometry (chapter 2). We concluded that home spirometry generates 
reproducible and quality acceptable PEF and FEV1 measurements. Although they are 
lower than those obtained by hospital spirometry and these results can not be used 
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Table 1. Mean spirometry data for the whole study population.(chapter 2} 
Mean ± SD 
Home spirometer 
Mean PEF (L/min) 278 ± 78 
Mean FEV1 { L) 2.35 ± 0.75 
Pneumotachograph 
Mean PEF (L/min) 300 ± 91 
Mean FEV1 (L) 2.41 ± 0.79 
Between devices 
Mean difference in PEF {L/min) 22 ± 29 








PEF: peak expiratory flow; FEV1: forced expiratory volume in the first second; SD: standard deviation. 
interchangeably, home spirometry appears to be suitable to assess peak flow and 
FEV1, and their diurnal variation at home (chapter 2). 
Home spirometry and monitoring disease severity 
This thesis shows that the relationsh ip of lung function variation (both PEF and 
FEV1), as assessed by home spirometry, to other parameters of asthma severity, such 
as airway hyperresponsiveness, bronchodilator response, asthma symptom scores 
and quality of life, is h ighly variable between patients and is therefore too 
inconsistent to be clinically useful (chapter 3}. We also showed that the poor 
concordance of PEF variation, assessed by using mechanical PEF meters and written 
PEF diaries, 5'6 to other parameters of asthma severity is not overcome by using 
electronic home spirometers. Furthermore, th is thesis found that the degree of 
airway narrowing at times of respiratory symptoms, prompting the use of reliever 
therapy, is highly variable between children with asthma (figure 4; chapter 4). 
Due to th is h ighly variable relationship between symptoms, FEV1 and PEF between 
patients, it is unclear what change in which parameter the patient is expected to 
respond to when monitoring and self-managing the disease at home, and whether 
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Figure 4. Home spirometry and symptom scores: Symptom free days compared to 'at 
times of symptoms'. •: symptom free days (SFD); o : at times of symptoms (ATOS}. VAS: 
visual analogue scale expressed as percentage of personal best value; PEF: peak 
expiratory flow expressed as percentage of personal best value; FEV1 : forced expiratory 
volume in one second expressed as percentage of predicted value.(chapter 4) 
monitoring are well recognized, 19'20 only one RCT on the usefulness of home 
spirometry was conducted to date. This study found no beneficial contribution of 
home spirometry to important self-management decisions, such as taking reliever 
medication, and did not improve asthma control or outcome.21 In addition, this 
thesis provides evidence of poor concordance of home spirometry with asthma 
severity and acute symptoms, and it shows that these relationships also vary 
considerably between patients. Taken together, these results limit the usefulness of 
home spirometry in the monitoring and management of childhood asthma (chapters 
3 and 4). 
129 
Usefulness of home spirometry in childhood asthma 
Peak expiratory flow versus FEV1 
It is generally assumed that home or hospital PEF measurements are of limited use 
because they are dependent on the patient's effort, and they mainly reflect large 
airway calibre instead of the increased small airways resistance characteristic of 
asthma.22'23 FEV1 is less dependent than PEF on the patient's effort and is a better 
estimate of smaller airways obstruction.8'23-25 Theoretically, therefore, home 
monitoring of FEV1 could provide a more reliable assessment of variation of airways 
obstruction than PEF monitoring. Although home spirometry provides reproducible 
and quality acceptable PEF and FEV1 measurements (chapter 2), we found an 
unexpected poor concordance of changes in PEF with changes in FEV1 (chapter 3). 
Similarly, falls in PEF below commonly used cut-off values for stepping up asthma 
therapy in self-management plans were accompanied by a wide range of drops in 
FEV1 and vice versa (chapter 3). 
It is quite clear that monitoring both parameters simultaneously in a self­
management plan would cause uncertainty, because it is unclear which change the 
patient is expected to respond to. With discordance between PEF and FEV1 changes 
occurring in approximately 33% of children with mild-to-moderate asthma, self­
management would become unacceptably complicated in many patients with 
asthma (chapter 3}. This poor concordance may be caused by the superiority of FEV1 
to reflect airways obstruction.8'23-25 However, the relationship of FEV1 variation to 
other parameters of asthma severity was as variable as that of PEF variation (chapter 
3). Furthermore, we found no difference between PEF and the potentially more 
sensitive FEV1 decrease at time of respiratory symptoms (chapter 4). These data are 
in accordance with the results of the RCT using home spirometry in self­
management, which found no increased sensitivity in monitoring FEV1 as a 
secondary outcome, when compared to PEF.21 These results, therefore, suggest that 
home spirometry FEV1 measurements also have limited value for home monitoring 
purposes. Apparently, the theoretical advantage of home FEV1 measurements does 
not come true in practice. 
Monitoring acute symptoms 
In the last edition of international asthma guidelines, assessment of asthma control 
has become the cornerstone of asthma monitoring and follow-up 3A,26 (table 2). This 
assessment of asthma control is largely based on the patient's perception of acute 
symptoms and the need for reliever therapy.3,4 It is suggested that the symptoms 
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that children experience represent a sum of different asthma-related sensations and 
perceptions over time, whilst lung function represents a snapshot impression of 
asthma status at a given point in time.21 Since many children with asthma, as well as 
their parents, are poor perceivers of airway obstruction, 22'27'28 relying only on the 
patient's recognition of asthmatic symptoms may lead to both overtreatment or 
undertreatment.22'28'29 This is why monitoring of lung function is advocated in 
asthma guidelines.3,4 
This thesis, however, found that patients vary considerably in the relationships 
between symptom scores, PEF and FEV1 (chapter 3 and 4). In addition, the degree of 
airway narrowing at times of respiratory symptoms, prompting the use of reliever 
therapy, was also highly variable between children with asthma (chapter 4). This 
finding hampers the applicability of the approach of variable inhaled corticosteroid 
and long-acting beta-2-agonist dosing in children.30 Overall, although PEF and FEV1 
were significantly lower at time of symptoms than at moments when the patient was 
asymptomatic, this change was both highly variable between patients and relatively 
small (6.6% for personal best PEF, and 6.0% for %predicted for FEV1 ) ;  the change in 
symptom scores between times of symptoms and asymptomatic days was much 
larger {36.2% for personal best) (chapter 4). In addition, the distributions of PEF and 
FEV1 in individual patients showed complete overlap between symptom-free days 
Table 2. Levels of asthma controle. From the G INA guidelines.4 
Characteristic 
Controlled (all Partly controlled (any 
Uncontrolled 
of the following measure present in any week) 
Daytime symptoms 
None (twice or 
More than twice/week 
less/week) 
Limitations of activities None Any Three or more 




Need for reliever/rescue None (twice or 
More than twice/week 
asthma present 
treatment less/week) in any week 
Lung function (PEF or 
normal 
< 80% predicted or personal 
FEV1) best (if known) 
Exacerbations None One or more/year 
One in any 
week 
* 
By definition, an exacerbation in any week makes that an uncontrolled asthma week. 
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and at time of symptoms {figure 4){chapter 4). Because no gold standard exists to 
determine whether the symptom scores or the home spirometry results adequately 
reflect asthma status, only RCTs using symptoms scores versus home spirometry can 
answer the question wh ich parameter should be used. A recent systematic review 
on this subject, including only one RCT using home spirometry in children, 21 showed 
that monitoring symptom scores is superior to PEF monitoring in childhood 
asthma.31 However, the children in our study, as a group, showed more symptoms 
than could be explained by their degree of airway narrowing. Apparently, children 
with asthma commonly report dyspnea or wheeze without objective evidence of 
airway obstruction (chapter 4). In conclusion, home PEF or F EV1 monitoring offers no 
advantage over symptom monitoring in the follow-up of asthma in children, 
therefore home PEF or FEV1 monitoring should not be advocated in asthma 
guidelines. 
Different association patterns 
In this thesis, we describe four different association patterns between symptom 
scores and lung function variation over time in ch ildren with asthma: reasonable 
concordance, chaos, poor perception or excessive symptoms {figure 5; chapters 3 
and 4). These association patterns are based on visual inspection and classification of 
home spirometry and symptom diary data, and arose from the observation that 
although PEF variation reflected the variability of the asthma symptom scores in 
some patients, in most cases there appeared to be no relationship at all. These 
observations concur with earlier studies using mechanical PEF meters.32 Identifying 
poor perceivers and patients with excessive symptoms would be clinically useful, and 
thus may help to predict functional morbidity of asthma in ch ildren.24 However, to 
be clinically useful, such a classification system of patients should be 
straightforward, and should be repeatable between observers. 
We found a fair inter-rater agreement of this preliminary classification system 
(chapter 4). Further studies are needed to develop a more robust and repeatable 
classification system of poor perception and excessive symptoms, with or without 
the use of home spirometry. Ideally, such a system should provide a clear and 
consistent signal to patients how they need to respond. Given the high variability 
between patients in symptom scores, PEF, and FEV1, and their agreement over time, 
the development of such a system is expected to be fraught with difficulties. 




0 10 20 30 40 50 60 70 80 90 
Chapter 7 
B) Dissociation or chaos 
0 10 20 30 40 50 60 70 80 90 





C) Poor perceiver 
10 20 30 40 50 60 70 80 90 







D) Excessive sym ptom s 
W 20 30 40 50 60 M 80 90 
Study period (days) 
Figure 5. Samples of individual monitoring data showing four different patterns of 
relationships between asthma severity score, forced expiratory volume in one second 
(FEV1) and peak expiratory flow (PEF) variation. a) : concordance of patients ; b) :  
dissociation or chaos; c) : poor perceiver; and d) : excessive symptoms 
categories.(chapter 3} --: asthma severity score (percentage of personal best); !).: 
PEF variation (expressed as size of day's range as a percentage of the day's mean 
(ampl/mean); .A :  FEV1 variation (ampl/mean).(chapter 3} 
symptoms of asthma and lung function variation over time is highly variable 
between patients, and chaotic and erratic in many. Again, th is limits the usefulness 
of home spirometry as a monitoring tool in chi ldhood asthma. 
133 
Usefulness of home spirometry in childhood asthma 
The role of home spirometry in diagnosing asthma 
Although it is still advocated in asthma guidelines for monitoring purposes,4 the role 
of assessing PEF variation as a diagnostic tool for asthma in children is 
questioned.3'7'3 3'34 This is mainly based on the finding that healthy ch ildren exhibit 
high levels of PEF variation, with a median of 8.2%, and a 95th percentile as h igh as 
31%.35 These PEF variation values show large overlap with those in children with 
asthma,5-7 and this limits the usefulness of PEF variation in distinguish ing ch ildren 
with asthma from healthy children. Because these results were obtained with 
unreliable written PEF diaries, we decided to study PEF and FEV1 variation in healthy 
schoolchildren using home spirometry (chapter 5). This study yielded a reliable single 
reference value of lung function variation for all schoolchildren, which is 
substantially lower that previously described in studies using mechanical PEF meters 
and written PEF diaries 35 (table 3). 
Given the low level of lung function variation found in healthy children (chapter 5) 
and the much higher degree of lung function variation found in children with 
persistent asthma (chapter 3), we hypothesized that home spirometry could be used 
as a diagnostic tool for asthma in children with nonspecific respiratory symptoms. 
The diagnostic study we designed to test this hypothesis, however, showed that 
home spirometry is of limited value in making or excluding the diagnosis of asthma 
in schoolchildren with nonspecific respiratory symptoms, such as cough and 
breathlessness, with likelihood ratios of 1.77 and 5.85 for PEF and FEV1 variation, 
respectively (chapter 6). 
Table 3. Old (1991) and new (2008) reference values for diurnal variation of PEF (and FEV1), obtained 
by using mechanical PEF meters and written PEF diaries35 and by using home spirometry with 
electronic data storage (chapter 5). 
PEF (ampl%mean) FEV1 (ampl%mean) 
Age groups 
95th percentile 95th percentile Mean (95%CI) Mean (95%CI) 
6-14 yr olds (n=159) 8.2 (not available) 31.0 not available not available 
6-16 yr olds (n=204)
t 
6.2 (5.8-6.7) 12.3 5.7 (5.4-6.1) 11.8 
•ouackeboss et al35; Brouwer et al (chapter 5}; PEF: peak expiratory flow; FEV1 : forced expiratory volume in 
one second; ampl%mean: Amplitude of variation % mean; Cl: confidence interval. 
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Although the likelihood ratio of 5.85 for FEV1 variation seems adequate, the 
sensitivity of increased FEV1 variation was poor, identifying less than half of the 
asthmatics in the study (chapter 6). Although the study was underpowered, the 
small difference and the complete overlap in PEF and FEV1 variation between the 
asthmatics and non asthmatics limits the usefulness of home spirometry in making 
the diagnosis of asthma in schoolchildren with nonspecific respiratory symptoms 
(chapter 6}. Therefore, even if obtained by electronic home spirometry, both PEF 
and FEV1 variation can not be used as a diagnostic tool for asthma in children with 
nonspecific chronic respiratory symptoms. 
Overall conclusions 
The studies in this thesis show that: 
1 The unreliability of written PEF diaries can be overcome by using home 
spirometry (chapter 2). 
2 The poor concordance of PEF variation with other parameters of asthma 
severity limit the usefulness of home spirometry for monitoring disease 
severity in childhood asthma (chapters 3 and 4). 
3 The poor concordance of changes in PEF variation with changes in symptom 
scores in children with asthma makes it unclear which patient should 
respond to what change in which parameter, further limiting home 
spirometry as a monitoring tool in childhood asthma (chapters 3 and 4). 
4 The reliable single reference value of lung function variation for 
schoolchildren, obtained by home spirometry, is substantially lower than the 
one previously described (chapter 5). 
5 The marginal contribution of lung function variation to make the diagnosis 
of asthma limits home spirometry as a diagnostic tool for childhood asthma 
(chapter 6). 
6 The potential benefit of the ability of home spirometry to measure FEV1 in 
addition to PEF could not be proven (chapters 3, 4 and 6). 
7 Based on the results presented in this thesis and the proven superiority of 
monitoring symptoms over lung function variation,31 international 
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guidelines should discourage the use of home spirometry routinely for both 
monitoring and diagnosing asthma in ch ildren (chapters 3, 4 and 6). 
Directions for further research 
1 Development of a robust classification system of poor perception and 
excessive symptoms to identify wh ich patients may ultimately benefit from 
the use of home spirometry (chapters 3 and 4). 
2 Home spirometry may prove useful in monitoring other respiratory diseases 
displaying less variation and a more gradual change, for example in cystic 
fibrosis.36 Ch ildren will have to perceive a clear benefit of their effort to 
prevent low adherence with long-term monitoring of home spirometry 
(chapters 3, 4, 5 and 6). 
3 In clinical studies, home spirometry in ch ildhood asthma can provide 
additional information at group level {chapters 3 and 4) and although the 
device used will need in vivo validation within the patient group studied 
(chapter 2), the provided reference values of healthy chi ldren can be used, 
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Although the Global Initiative on Asthma {GINA) guidelines advocate home 
monitoring of peak flow in the follow-up of asthma to assess disease severity and to 
help in making the diagnosis of asthma in ch ildren, th is recommendation is not 
based on good evidence. The evidence available to date is mainly based on written 
PEF diaries, wh ich have proven to be unreliable. Because th is unreliability does not 
apply to electronic home spirometry, home spirometers are assumed to be a 
suitable alternative monitoring and diagnostic tool for asthma in ch ildren. The main 
aim of th is thesis was to assess the usefulness of home spirometry in monitoring 
disease severity and in making the diagnosis of ch ildhood asthma. 
Validation: All studies in th is thesis used the same electronic portable spirometer 
(Koko Peak Pro), wh ich had been validated in vitro previously. 
In chapter 2, we examined the validity of th is home spirometer in vivo by studying 
the agreement between lung function variables measured by home spirometry and 
those obtained by hospital lung function measurement on a pneumotachograph. 
The home spirometer produced reproducible and quality acceptable PEF and FEV1 
measurements. The PEF and FEV1 measurements were significantly lower than those 
obtained on the hospital spirometer (mean difference in PEF (L/min): 22; 95%CI: 14-
30, and mean difference in FEV1 (L): 0.06 95%CI: 0.02-0.10). This means that, 
although FEV1 and PEF measurements obtained by hospital or home spirometers can 
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not be used interchangeably, the home spirometer is suitable to assess diurnal 
variation of peak flow and FEV1, or to longitudinally assess actual peak flow and FEV1 
at home. Therefore, the Koko Peak Pro can be used for home recording of lung 
function under field conditions. 
Monitoring: Previous studies, using written PEF diaries, have examined the 
relationsh ip between peak flow (variation} and other indices of asthma severity, and 
found that monitoring PEF alone is insufficient to assess asthma severity adequately. 
Due to the unreliability of written PEF diaries, however, it is uncertain whether these 
earlier results are valid. 
In chapter 3, we used the home spirometer to assess the relationships between lung 
function variation, asthma symptom scores and other indices of asthma severity in 
ch ildren with mild-to-moderate asthma using inhaled corticosteroids. We found that 
the relationsh ip of lung function variation of both PEF and FEV1 to other parameters 
of asthma severity, such as airway hyperresponsiveness, bronchodilator response, 
asthma symptom scores, and quality of life, was h ighly variable between patients 
and, therefore, too inconsistent to be clinically useful. 
In chapter 4, we used home spirometry to prospectively study whether symptoms, 
prompting the use of reliever therapy, are accompanied by changes in lung function. 
We found that the degree of airway narrowing at these times of respiratory 
symptoms is also highly variable between children with asthma. If both symptoms 
and lung function are monitored in asthma self-management programs, the variable 
concordance between the two make it unclear what change in wh ich parameter the 
patient is expected to respond to, and whether th is response influences clinically 
relevant outcomes, such as exacerbation rates and quality of life. These results limit 
the usefulness of home spirometry as a monitoring tool in ch ildhood asthma. 
Diagnosis: In chapter 5, we describe a study aimed at establishing reliable reference 
values for lung function variation using electronic home spirometry. We found 
substantially lower variation of lung function in healthy schoolchildren than 
previously described, with a smaller degree of overlap with values obtained in 
children with asthma. Th is prompted us to re-examine the role of home spirometry 
as a diagnostic tool for childhood asthma. 
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In chapter 6, we prospectively explored the usefulness of lung function variation 
assessed by home spirometry in diagnosing asthma in children with nonspecific 
respiratory symptoms, such as cough and breathlessness. Although children in 
whom asthma was diagnosed had a higher mean degree of PEF and FEV1 variation 
than children without asthma, the overlap between the two groups was 
considerable, and the diagnostic value of increased PEF or FEV1 variation in making 
the diagnosis of asthma in those children was limited. 
Overall conclusion: The studies in this thesis showed that the unreliability of written 
PEF diaries can be overcome by using home spirometry. However, the relationship of 
PEF and FEV1 variation to other indices of asthma severity (such as symptoms and 
lung function) was highly variable between patients, both cross-sectionally and 
longitudinally. In addition, home spirometry had poor diagnostic value in identifying 
asthma in children with nonspecific respiratory symptoms such as cough and 
breathlessness. This thesis thus shows that the usefulness of home spirometry in 
childhood asthma, whether for monitoring disease severity or for making the 
diagnosis of asthma, is limited. We propose, therefore, to remove home spirometry 
as a diagnostic or monitoring tool for childhood asthma from asthma guidelines. 
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De diagnose astma wordt bij ongeveer 4% van de kinderen in Nederland gesteld. 
Daarmee is het een van de meest voorkomende chronische aandoeningen bij 
kinderen. Astma is een aandoening van de luchtwegen, waarbij chronische 
ontsteking een centrale rol speelt. De luchtwegen zijn daardoor overgevoelig 
(hyperreactief) voor verschillende prikkels, zoals huisstofmijt, huidschilfers en haren 
van (huis)dieren, boom- en graspollen, en sigarettenrook. Het gevolg is dat 
benauwdheid optreedt door slijmvlieszwelling en het samenknijpen van de 
geprikkelde luchtwegen (luchtwegobstructie). 
De behandeling van astma bij kinderen omvat een aantal belangrijke kernelementen. 
Diagnose: Allereerst moet uiteraard de diagnose warden gesteld. De diagnose astma 
wordt vooral gebaseerd op de klachten die kinderen ervaren, zoals terugkerende 
momenten van benauwdheid, piepen en hoesten. Helaas is er geen eenduidige test 
om de diagnose betrouwbaar te stellen. Wei kan de verdenking op astma warden 
ondersteund door longfunctieonderzoek. Met dit longfunctieonderzoek kan 
bijvoorbeeld de eensecondewaarde warden gemeten (de hoeveelheid lucht, in liters, 
die in de eerste seconde van een geforceerde uitademing wordt uitgeblazen), en de 
verbetering of verslechtering van deze eensecondewaarde op respectievelijk 
luchtwegverwijders (reversibiliteit), of juist op prikkels (hyperreactiviteit). Het nadeel 
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is dat deze longfunctiemetingen in het ziekenhuis moeten plaatsvinden. Hierdoor 
zijn het slechts momentopnames, terwijl astma juist wordt gekenmerkt door een 
wisselende mate van luchtwegobstructie. 
Beperking van b/ootstelling aan prikkels: De klachten van astma kunnen verergeren 
door blootstelling aan verschillende factoren zoals de eerder genoemde prikkels, 
maar ook als gevolg van virale luchtweginfecties en emoties. ldentificatie van deze 
uitlokkende factoren, en waar mogelijk een verminderde blootstelling daaraan, kan 
het astma verbeteren en de hoeveelheid benodigde medicijnen beperken. 
Medicatie: De ervaren benauwdheid kan warden bestreden door de inhalatie van 
luchtwegverwijders {beta-2-agonisten), die in principe aan alle kinderen met astma 
warden voorgeschreven. Deze luchtwegverwijders werken vaak goed en snel, maar 
pakken de uiteindelijke oorzaak van de benauwdheid {de chronische ontsteking) niet 
aan. Door de chronische ontsteking met ontstekingsremmers {inhalatie 
corticostero'iden), te bestrijden, warden de luchtwegen minder gevoelig en treedt de 
benauwdheid minder vaak op. Het ophogen of afbouwen van deze medicijnen 
gebeurt stapsgewijs en wordt gedaan op basis van de klachten die kinderen {nog) 
ervaren en de hoeveelheid luchtwegverwijders die kinderen {nog) nodig hebben. 
Educatie en partnerschap: Het overdragen van kennis over astma en het aanleren 
van vaardigheden die nodig zijn om op de juiste manier {en op het juiste moment) 
inhalatiemedicijnen te gebruiken, zijn essentiele elementen van de behandeling van 
astma, om uiteindelijk de patient en zijn of haar ouders stapsgewijs meer 
verantwoordelijkheid te kunnen geven in het zelfmanagement van de behandeling. 
Het partnerschap dat de patient en zijn of haar ouders daarmee met de behandelaar 
aangaan, vormt de basis voor het vertrouwen wat nodig is om met effectief 
zelfmanagement het astma onder controle te krijgen en te houden. 
Monitoren: Het is van belang om tijdens de behandeling regelmatig te controleren 
hoe het met de ziekte gaat. Niet alleen om een eventuele verslechtering van het 
astma snel op te sporen en te behandelen, maar ook om medicijnen af te kunnen 
bouwen als het goed gaat. Helaas is het zo dat veel kinderen pas heel laat aan hun 
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klachten merken dat het niet goed gaat met hun astma. Daarom is het, naast het 
bespreken van klachten en medicijngebruik, ook belangrijk om objectief te meten 
hoe het met het astma gaat. Daarvoor worden vooral de eerder genoemde, 
ziekenhuisgebonden longfunctieonderzoeken gebruikt. Hiermee wordt echter alleen 
de toestand op het moment van de meting bepaald. Gezien het wisselende karakter 
van astma zou het wellicht beter zijn om dagelijks thuis de longfunctie te bepalen. 
Hiervoor is indertijd de piekstroommeter ontwikkeld. Dit is een simpel apparaatje, 
dat de maximale snelheid van de luchtstroom (piekstroom) meet, in liters per 
minuut, bij een geforceerde uitademing. Hiermee zou thuis een indruk kunnen 
worden verkregen van de mate van vernauwing van de luchtwegen en daarmee van 
de variatie van het astma. 
Achtergrond van dit proefschrift: Het thuis monitoren van de ernst van astma bij 
kinderen met behulp van piekstroom (mechanisch) of thuisspirometrie (elektronisch) 
wordt geadviseerd in internationale richtlijnen, zoals die van de 'Global Initiative on 
Asthma (GINA)'. Ook wordt toegenomen piekstroomvariatie als een diagnostisch 
criterium gezien. Deze stellingname is echter vooral gebaseerd op logisch redeneren; 
er is nauwelijks wetenschappelijk bewijs te vinden voor het nut van 
piekstroomregistratie bij de diagnostiek of het monitoren van astma bij kinderen. 
Het beperkt aanwezige bewijs is uitsluitend gebaseerd op met de hand bijgehouden 
piekstroomdagboekjes, die uitermate onbetrouwbaar zijn gebleken. Aangezien 
elektronische thuisspirometers de longfunctiewaarden op een microchip registreren 
en daarmee de onbetrouwbaarheid van de piekstroomdagboekjes omzeilen, wordt 
thuisspirometrie gezien als een nuttige methode om de ernst van astma bij kinderen 
te monitoren, en ook als test om de diagnose astma betrouwbaar te kunnen stellen. 
Het doel van dit proefschrift was om de betrouwbaarheid en het nut van 
thuisspirometrie te onderzoeken bij het monitoren van de ernst van astma bij 
kinderen, en bij het stellen of verwerpen van de diagnose astma bij kinderen. 
Betrouwbaarheid van thuisspirometrie: Alie studies beschreven in dit proefschrift 
hebben gebruik gemaakt van een zelfde soort elektronische thuisspirometer ( Koko 
Peak Pro). Deze thuisspirometer was al in het laboratorium (in vitro) gevalideerd, 
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door de resultaten te vergelijken met die van computersimulaties, zoals aanbevolen 
in de internationaal geldende richtlijnen. 
In hoofdstuk 2 onderzochten wiJ Je betrouwbaarheid van deze thuisspirometer bij 
kinderen (in vivo), door op hetzelfde moment de longfunctiewaarden verkregen met 
de thuisspirometer te vergelijken met de metingen op een longfunctieapparaat 
(pneumotachograaf) in het longfunctielaboratorium. De piekstroom en 
eensecondewaarde verkregen met de thuisspirometer bleken goed reproduceerbaar 
en van acceptabele kwaliteit. Ze waren echter wel wat lager dan de waarden 
verkregen met de ziekenhuispneumotachograaf, waardoor metingen van 
thuisspirometrie niet onderling uitwisselbaar zijn met ziekenhuismetingen. De Koko 
Peak Pro is wel geschikt om de longfunctie thuis dagelijks te vervolgen, om daarmee 
de variatie van de longfunctie te berekenen. 
Thuisspirometrie en het monitoren van astma: De relatie tussen piekstroomvariatie 
en andere uitingen van ernst van astma is eerder alleen onderzocht met behulp van 
de onbetrouwbaar gebleken piekstroomdagboekjes. Daarom hebben wij de variatie 
van longfunctie, gemeten met een thuisspirometer, vergeleken met ander maten 
voor de ernst van astma bij kinderen. 
In hoofdstuk 3 maakten we gebruik van elektronische thuisspirometrie om het 
verband (de correlatie) te bepalen tussen de variatie van longfunctie, symptoom 
scores en andere metingen van de ernst van het astma bij kinderen die in verband 
met mild tot matig persisterend astma inhalatie corticostero"iden als 
onderhoudsbehandeling gebruikten. Uit dit onderzoek bleek dat de correlatie tussen 
enerzijds de variatie van piekstroom en eensecondewaarde en anderzijds de overige 
onderzochte parameters van astma (prikkelbaarheid van de luchtwegen, 
verandering van luchtwegobstructie na inhalatie van een luchtwegverwijder, 
symptoom scores en kwaliteit van leven) zeer variabel is tussen astma patienten. Dit 
heeft tot gevolg dat de waarde van thuisspirometrie als instrument om de ernst van 
astma bij kinderen te vervolgen in de klinische praktijk beperkt is. 
I n  hoofdstuk 4 hebben we vervolgens onderzocht of bij een vergelijkbare groep 
kinderen met astma een daling in longfunctie aantoonbaar was, op het moment dat 
ze luchtwegverwijders wilden gaan gebruiken voor acute benauwdheidklachten. I n  
dit onderzoek bleek dat oak de mate van daling in  longfunctie ten tijde van acute 
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benauwdheidklachten tussen de patienten zeer variabel was. Als kinderen met 
astma dagelijks thuis klachtenscores en longfunctie bijhouden is het door de 
variabele relatie tussen deze twee fenomenen onduidelijk of kinderen met astma 
hun medicatie zouden moeten aanpassen op basis van hun klachten, of op basis van 
een daling in longfunctie. Daarnaast is het de vraag of een dergelijke aanpassing van 
medicatie op geleide van het monitoren thuis, de mate van astma controle 
verbetert. In eerder onderzoek is geen gunstig effect aangetoond van het monitoren 
van piekstroom en eensecondewaarde thuis, op belangrijke uitkomsten van astma 
bij kinderen. De resultaten van dit proefschrift maken nog duidelijker dat het 
dagelijks monitoren van piekstroom of eensecondewaarde met thuisspirometrie 
geen toegevoegde waarde bij de behandeling en follow-up van kinderen met astma 
heeft. 
Thuisspirometrie en het stellen van de diagnose astma: In hoofdstuk 5 warden 
nieuwe normaalwaarden van variatie van longfunctie bij gezonde kinderen 
beschreven, die zijn bepaald met behulp van thuisspirometrie. De variatie van 
longfunctie bij gezonde kinderen bleek duidelijk lager dan eerder beschreven 
normaalwaarden die waren verkregen met behulp van de (onbetrouwbare} 
piekstroomdagboekjes, en ook minder overlap te vertonen met waarden bij 
kinderen met astma. Hierdoor zou thuisspirometrie wellicht een instrument kunnen 
zijn om de diagnose astma bij kinderen te kunnen stellen. 
In hoofdstuk 6 wordt een studie beschreven waarin we de waardt 
thuisspirometrie als diagnostisch instrument onderzoeken bij kinderen, bij wie de 
huisarts twijfelt of de klachten van hoesten of kortademigheid op astma zouden 
kunnen berusten. De bijdrage van thuisspirometrie aan het meer of minder 
waarschijnlijk maken van astma bleek echter marginaal, waardoor thuisspirometrie 
geen goed diagnostisch instrument is om de diagnose astma te stellen bij kinderen 
met aspecifieke luchtwegklachten. 
Conclusies: Uit de beschreven studies in dit proefschrift blijkt dat thuisspirometrie 
geschikt is om in de klinische praktijk de (variatie van} longfunctie in de loop van de 
tijd te vervolgen, niet gehinderd door de onbetrouwbaarheid van de 
handgeschreven piekstroomdagboekjes. De waarde van thuisspirometrie bij 
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kinderen met astma blijkt echter beperkt, zowel bij het monitoren van de ernst van 
astma, als bij het stellen van de diagnose. Dit komt vooral omdat er zo'n groot 
verschil is tussen patienten met astma in de mate van variatie van longfunctie, en de 
relatie daarvan met klachtenscores en andere uitingen van ernst van astma. Naar 
onze mening is er dus geen rol weggelegd voor thuisspirometrie bij de diagnostiek of 
het monitoren van astma bij kinderen, en zouden de internationale astmarichtlijnen 
navenant moeten warden aangepast. 
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Zo, deze mijlpaal is bereikt en al die tijd heb ik met heel veel plezier aan de 
onderzoeken van dit proefschrift gewerkt. Hoewel de laatste loodjes het zwaarst 
wegen, heeft dit lange traject bij ans thuis oak rust gebracht. Zwolle kon als stad 
voor een langere tijd ans thuis zijn en mede daardoor hebben we al die leuke, lieve 
en interessante mensen ontmoet, die ans hebben bijgestaan in de drukte, stress, en 
al het 1extra naast de toch al pittige opleiding', maar oak bij de geboorte van onze 
twee prachtige dochters. 
Onderzoek doe je niet alleen en voor de totstandkoming van dit boekje ben ik 
verscheidene mensen heel veel dank verschuldigd. 
Allereerst wil ik mijn promotores en begeleiders Paul Brand, Ruurd Jan Roorda en 
Eric Duiverman bedanken. 
Beste Paul, ik weet niet goed in woorden uit te drukken hoe groat de rol is, die jij tot 
nu toe hebt gespeeld. Toch ga ik een paging doen. Dit project heeft waarschijnlijk 
voor jou al z'n oorsprong in de tijd dat jij zelf promoveerde bij prof Dirkje Postma. 
Voor mij began het toen ik als co-assistent en daarna als arts-assistent niet-in­
opleiding bij jullie in 1de Weezenlanden' werkzaam was. Na 1 jaar en met die 
felbegeerde opleidingsplaats op zak, kreeg ik van jou {en Ruurd Jan) het vertrouwen 
om dit project voor een groat deel zelfstandig uit te werken met als doel en resultaat 
dit proefschrift. Mooie momenten waren het 1oogsten1 op de internationale 
congressen met verscheidene presentaties en geaccepteerde artikelen, niet alleen 
voor dit proefschrift. Minder prettig was het getouwtrek met de CCMO over dat deel 
wat we uiteindelijk door een tekort aan inclusies niet eens hebben kunnen 
voltooien. We zijn daarvoor zelfs samen een keer op het ministerie in Den Haag 
geweest. Ondertussen ben je oak mijn opleider tijdens mijn perifere stage in Zwolle 
geweest en nu zelfs 2e promotor. Je stand altijd voor me klaar met raad, maar oak 
daad als ik daar om vroeg. Daarnaast gaf je me het vertrouwen dat het goed kwam 
door ruimte te bieden als het even niet zo vlotte. Jouw interesse en betrokkenheid 
reiken verder dan alleen professioneel. Het toppunt was de schrijfstage in 
Groningen, die gepland was random de geboorte van Nynke Mirthe, zodat ik niet 
alleen tijd kreeg om in Zwolle in plaats van Groningen te gaan schrijven, maar oak de 
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eerste weken van Nynke Mirthe thuis intensief kon meebeleven. lk heb van jou heel 
veel geleerd en hoop dat, in welke vorm dan ook, nog lang te mogen doen. 
Beste Ruurd Jan, begeleider van het eerste uur en Zwolse collega van Paul. Ook van 
jou kreeg ik het volste vertrouwen voor het nu afgeronde project. Het onderzoek 
beschreven in hoofdstuk 4 heeft compleet jouw handtekening. Dat je in de loop van 
de tijd een andere weg in bent geslagen doet niets af aan de betrokkenheid die ik 
nog steeds voel. Je bent nu geen kinderarts meer, maar directeur van een compleet 
ziekenhuis. lk wil je enorm bedanken voor al je raad en adviezen, en ook voor de 
taalcorrecties van mijn Fries-Nederlands en de d's en t's. lk hoop je nog vaak tegen 
te komen. 
Beste Eric, mijn begeleider vanuit Groningen en eerste promotor. Vanaf het begin 
heb jij je vertrouwen gegeven aan 'het Zwolse team' en halverwege het traject werd 
je steeds actiever betrokken. lk heb je commentaren en positieve aanmoedigingen 
altijd zeer gewaardeerd. Ook de gesprekken die we samen hebben gehad, zowel in 
de rol van (plaatsvervangend) opleider in Groningen als in de rol van promotor, 
hebben me elke keer goed gedaan. lk wil je daar enorm voor bedanken en we zullen 
elkaar nog vaak tegenkomen. 
I would like to thank professor Wim van Aalderen, professor Andy Bush, and mw 
professor Dirkje Postma for their positive judgement of the manuscript and for their 
willingness to act as opponents at the defence of this thesis. 
Mijn paranymfen Folkert Leenstra en Jeroen Steeman. Beste Folkert, ik beschouw je 
niet alleen als zwager, maar ook als goede vriend. Jij hebt in jouw leven al heel veel 
meer meegemaakt en gezien, dan menig ander ooit zal doen. De tijd dat je bij ons in 
huis hebt gewoond, beschouwen Teatske en ik allebei als zeer speciaal. lk vind het 
een eer dat jij mij bij wilt staan tijdens de verdediging van dit proefschrift. Beste 
Jeroen, goede vriend. Jij bent een van die leuke, lieve en speciale mensen die we in 
Zwolle hebben ontmoet. Samen de Ventoux op fietsen was werkelijk werelds en ik 
vind het fantastisch dat je nu naast me staat. 
Kinder(long)artsen Arvid Kamps en Bart Rottier. Jullie waren de onafhankelijke 
onderzoekers die al die piekstroom en eensecondewaarde curven hebben 
beoordeeld uit hoofdstuk 4. Heel erg bedankt voor die inzet. lk hoop dat de fies wijn 
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gesmaakt heeft (als die al is gearriveerd op het moment dat jullie dit lezen). Beste 
Arvid, het stokje als onderzoeker bij Paul is nu overgegeven aan Ted Kick, zeals jij het 
ooit al eens aan mij gaf. Je hebt het al eens eerder gezegd: 'lk kan me geen mooiere 
plek als arts-assistent/onderzoeker bedenken' . 
Kamergenoten Cathelijne Snijders en Ted Klok. Cathelijne, mijn eerste kamergenoot. 
Na de eerste onderzoeksjaren alleen in 'de Weezenlanden' te hebben gewerkt, 
deelden wij op de locatie 'Sophia' dat kleine kamertje waar het raam niet open kon. 
Samen konden wij onze frustraties delen en elkaars werk sterker maken. Als het 
goed is, staan we ongeveer gelijktijdig voor de 'Corona'; jij in Amsterdam en ik in 
Groningen. Heel veel succes met je verdere opleiding tot kinderarts. Beste Ted, next­
in-line als promovendus bij Paul. Een korte maar krachtige 3 maanden kon ik bij jou 
op de kamer dit proefschrift afronden. Om meerdere redenen heb ik genoten van 
die tijd en op het moment dat ik dit schrijf, moeten we samen nog naar Wenen om 
daar ons werk te presenteren. Je hebt daar in Zwolle een wereldse plek als arts­
assistent/onderzoeker. Geniet ervan. 
Ellen Ruberg, j ij hebt als longfunctie assistente, samen met je collega's, mij wegwijs 
gemaakt in het zelfstandig uitvoeren van longfunctie onderzoek bij kinderen. Weg 
die schroom: blazen, blazen, door, door, door ... En Ellen, sinds wij samen de smaak 
van de abstracts op het European Respiratory Society congres hebben geproefd, 
denk ik dat we elkaar ook daar nog regelmatig zullen treffen. Ellen en collega's, 
hartel ijk bedankt voor al jullie hulp. 
Chantal Visser, arts-assistent kindergeneeskunde in Zwolle en nu huisarts in 
opleiding in Groningen. Toen ik voor mijn opleiding weer in Groningen aan de slag 
moest, stand jij klaar om die laatste broodnodige patienten voor mij te includeren 
voor het onderzoek van hoofdstuk 6. Enorm bedankt voor je inzet en heel veel 
succes in je verdere carriere. Een opleidingsplaats in de kindergeneeskunde ging 
helaas aan jou voorbij, maar we zijn wel weer een hele goede huisarts rijker. 
Trinette Steenhuis, kinderarts-dus- inmiddels-niet-meer-in-opleiding in Utrecht. lk 
meet je tech even noemen, want zonder dit onderzoek zouden wij samen die autorit 
naar het European Respiratory Society congres in M0nchen nooit hebben gemaakt, 
en die was tech onvergetelijk. Heel veel succes met de afronding van jouw boekje en 
ik hoop je nog vaak te treffen. 
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Dit proefschrift was oak nooit tot stand gekomen zonder al die kinderen en ouders, 
die belangeloos hebben meegedaan aan de onderzoeken beschreven in dit 
proefschrift. Oak jullie wil ik daar enorm voor bedanken. 
Daarnaast is er een hele schare arts-assistenten kindergeneeskunde in Zwolle en 
Groningen en oak kinderartsen in Zwolle en Groningen die mij de ruimte hebben 
geboden, zowel letterlijk als figuurlijk, om dit uiteindelijk allemaal voor elkaar te 
krijgen. Heel erg bedankt voor jullie steun en geduld de afgelopen leuke jaren. In het 
bijzonder wil ik het secretariaat kindergeneeskunde in Zwolle bedanken, met aan het 
hoofd Marion Overmars, voor de professionele hulp die jullie hebben geboden en 
interesse die jullie altijd hebben getoond. 
Lieve Teatske, ik wil je bedanken voor al je steun en begrip elke keer dat de laptop in 
de avonduren op de tafel stand. Maar vooral wil ik je oak bedanken voor de keren 
dat je me achter de laptop vandaan haalde als ik teveel een kluizenaar dreigde te 
warden. Er is zoveel meer moois dan 'de opleiding' en 'het proefschrift'. Samen met 
jou en onze kinderen wil ik daar tot in lengte van dagen van blijven genieten. Lieve 
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in het ziekenhuis 1de Weezenlanden' in Zwolle, alwaar de basis is gelegd voor de 
onderzoeken beschreven in dit proefschrift. Op 1 april 2002 startte h ij in een 
combinatietraject van opleiding en onderzoek (AGIKO-schap) aan het Beatrix 
Kinderziekenhuis van het Univers itair Medisch Centrum Groningen, met als affiliatie 
de 1Amalia Kinderafdeling' van de lsala klinieken in Zwolle. Al het onderzoek 
besch reven in dit proefschrift, is uitgedacht en uitgevoerd aan de 1Amalia 
Kinderafdeling' van de lsala klinieken in Zwolle. Na afronding van dit proefschrift is 
h ij begonnen aan het laatste half jaar van de opleiding tot kinderarts in het Beatrix 
Kinderziekenhuis van het Universitair Medisch Centrum Groningen. In 2003 is h ij 
getrouwd met Teatske Leenstra, samen hebben zij twee schatten van dochters: 
Famke Anne (2007) en Nynke Mirthe (2009). 
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Dit proefschrift is gedrukt op papier dat afkomstig is uit duurzaam beheerde bossen. 
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